<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" id="jcmm70617" xml:lang="en" article-type="research-article"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">J Cell Mol Med</journal-id><journal-id journal-id-type="iso-abbrev">J Cell Mol Med</journal-id><journal-id journal-id-type="doi">10.1111/(ISSN)1582-4934</journal-id><journal-id journal-id-type="publisher-id">JCMM</journal-id><journal-title-group><journal-title>Journal of Cellular and Molecular Medicine</journal-title></journal-title-group><issn pub-type="ppub">1582-1838</issn><issn pub-type="epub">1582-4934</issn><publisher><publisher-name>John Wiley and Sons Inc.</publisher-name><publisher-loc>Hoboken</publisher-loc></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmid">40407710</article-id><article-id pub-id-type="pmc">PMC12101071</article-id><article-id pub-id-type="doi">10.1111/jcmm.70617</article-id><article-id pub-id-type="publisher-id">JCMM70617</article-id><article-id pub-id-type="other">JCMM-12-2024-205.R1</article-id><article-categories><subj-group subj-group-type="overline"><subject>Original Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Original Article</subject></subj-group></article-categories><title-group><article-title>Matrine Inhibits the Wnt3a/&#x003b2;&#x02010;Catenin Signalling to Attenuate Pressure Overload&#x02010;Induced Atrial Remodelling and Vulnerability to Atrial Fibrillation</article-title></title-group><contrib-group><contrib id="jcmm70617-cr-0001" contrib-type="author"><name><surname>Zhang</surname><given-names>Guoxin</given-names></name><xref rid="jcmm70617-aff-0001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib id="jcmm70617-cr-0002" contrib-type="author"><name><surname>Dong</surname><given-names>Xue</given-names></name><xref rid="jcmm70617-aff-0002" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib id="jcmm70617-cr-0003" contrib-type="author"><name><surname>Sun</surname><given-names>Boxuan</given-names></name><xref rid="jcmm70617-aff-0001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib id="jcmm70617-cr-0004" contrib-type="author"><name><surname>Zhou</surname><given-names>Zijun</given-names></name><xref rid="jcmm70617-aff-0001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib id="jcmm70617-cr-0005" contrib-type="author"><name><surname>Xu</surname><given-names>Yinli</given-names></name><xref rid="jcmm70617-aff-0001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib id="jcmm70617-cr-0006" contrib-type="author"><name><surname>Huang</surname><given-names>Yuting</given-names></name><xref rid="jcmm70617-aff-0001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib id="jcmm70617-cr-0007" contrib-type="author"><name><surname>Meng</surname><given-names>Shan</given-names></name><xref rid="jcmm70617-aff-0001" ref-type="aff">
<sup>1</sup>
</xref><xref rid="jcmm70617-aff-0003" ref-type="aff">
<sup>3</sup>
</xref></contrib><contrib id="jcmm70617-cr-0008" contrib-type="author"><name><surname>Cao</surname><given-names>Zijun</given-names></name><xref rid="jcmm70617-aff-0001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib id="jcmm70617-cr-0009" contrib-type="author"><name><surname>Qin</surname><given-names>Nana</given-names></name><xref rid="jcmm70617-aff-0001" ref-type="aff">
<sup>1</sup>
</xref><xref rid="jcmm70617-aff-0004" ref-type="aff">
<sup>4</sup>
</xref></contrib><contrib id="jcmm70617-cr-0010" contrib-type="author"><name><surname>Zhu</surname><given-names>Yan</given-names></name><xref rid="jcmm70617-aff-0001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib id="jcmm70617-cr-0011" contrib-type="author" corresp="yes"><name><surname>Yu</surname><given-names>Liming</given-names></name><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0001-5953-5016</contrib-id><xref rid="jcmm70617-aff-0001" ref-type="aff">
<sup>1</sup>
</xref><address><email>lmyu2012@163.com</email></address></contrib><contrib id="jcmm70617-cr-0012" contrib-type="author" corresp="yes"><name><surname>Wang</surname><given-names>Huishan</given-names></name><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0001-6523-7488</contrib-id><xref rid="jcmm70617-aff-0001" ref-type="aff">
<sup>1</sup>
</xref><address><email>huishanw@126.com</email></address></contrib></contrib-group><aff id="jcmm70617-aff-0001">
<label>
<sup>1</sup>
</label>
<named-content content-type="organisation-division">State Key Laboratory of Frigid Zone Cardiovascular Disease, Department of Cardiovascular Surgery</named-content>
<institution>General Hospital of Northern Theater Command</institution>
<city>Shenyang</city>
<named-content content-type="country-part">Liaoning</named-content>
<country country="CN">China</country>
</aff><aff id="jcmm70617-aff-0002">
<label>
<sup>2</sup>
</label>
<named-content content-type="organisation-division">The Third Outpatient Department</named-content>
<institution>General Hospital of Northern Theater Command</institution>
<city>Shenyang</city>
<named-content content-type="country-part">Liaoning</named-content>
<country country="CN">China</country>
</aff><aff id="jcmm70617-aff-0003">
<label>
<sup>3</sup>
</label>
<institution>Jinzhou Medical University</institution>
<city>Jinzhou</city>
<named-content content-type="country-part">Liaoning</named-content>
<country country="CN">China</country>
</aff><aff id="jcmm70617-aff-0004">
<label>
<sup>4</sup>
</label>
<institution>Liaoning University of Traditional Chinese Medicine</institution>
<city>Shenyang</city>
<named-content content-type="country-part">Liaoning</named-content>
<country country="CN">China</country>
</aff><author-notes><corresp id="correspondenceTo">
<label>*</label>
<bold>Correspondence:</bold>
<break/>
Liming Yu (<email>lmyu2012@163.com</email>)<break/>
Huishan Wang (<email>huishanw@126.com</email>)<break/>
</corresp></author-notes><pub-date pub-type="epub"><day>23</day><month>5</month><year>2025</year></pub-date><pub-date pub-type="collection"><month>5</month><year>2025</year></pub-date><volume>29</volume><issue seq="280">10</issue><issue-id pub-id-type="doi">10.1111/jcmm.v29.10</issue-id><elocation-id>e70617</elocation-id><history>
<date date-type="rev-recd"><day>17</day><month>4</month><year>2025</year></date>
<date date-type="received"><day>02</day><month>1</month><year>2025</year></date>
<date date-type="accepted"><day>12</day><month>5</month><year>2025</year></date>
</history><permissions><!--&#x000a9; 2025 Journal of Cellular and Molecular Medicine published by John Wiley & Sons Ltd and Foundation for Cellular and Molecular Medicine--><copyright-statement content-type="article-copyright">&#x000a9; 2025 The Author(s). <italic toggle="yes">Journal of Cellular and Molecular Medicine</italic> published by Foundation for Cellular and Molecular Medicine and John Wiley &#x00026; Sons Ltd.</copyright-statement><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an open access article under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link> License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="file:JCMM-29-e70617.pdf"/><abstract><title>ABSTRACT</title><p>Atrial fibrillation (AF) is closely associated with atrial electrical and structural remodelling, yet effective drug strategies remain limited. Matrine (MAT), the active compound in <styled-content style="fixed-case" toggle="no">
<italic toggle="no">Sophora flavescens</italic>
</styled-content>, has shown anti&#x02010;AF effects, but its mechanisms are unclear. This study explored MAT's impact on pressure overload&#x02010;induced AF using clinical samples, bioinformatics, network pharmacology and murine models, focusing on the canonical Wnt signalling. A murine pressure overload model was established via transverse aortic constriction (TAC) surgery for 4&#x02009;weeks. Programmed electrical stimulation, langendorff perfusion, echocardiography, Masson's trichrome staining and western blotting were used to evaluate the potential effects and mechanisms of MAT. The results demonstrated that TAC&#x02010;induced atrial electrical and structural remodelling significantly increased susceptibility to AF in mice while also up&#x02010;regulated atrial Wnt3a/&#x003b2;&#x02010;catenin signalling as well as markers for remodelling and inflammation, which were partially supported by clinical samples. MAT dose&#x02010;dependently mitigated atrial structural and electrical remodelling. Furthermore, MAT intervention inhibited Wnt3a/&#x003b2;&#x02010;catenin signalling. However, co&#x02010;administration of SKL2001, a Wnt/&#x003b2;&#x02010;catenin agonist, counteracted MAT's benefits. The overall findings suggest that MAT treatment may serve as a potential therapeutic approach for inhibiting TAC&#x02010;induced atrial electrical and structural remodelling by suppressing Wnt3a/&#x003b2;&#x02010;catenin signalling pathways, thereby reducing susceptibility to AF.</p></abstract><kwd-group kwd-group-type="author-generated"><kwd id="jcmm70617-kwd-0001">atrial fibrillation</kwd><kwd id="jcmm70617-kwd-0002">atrial remodelling</kwd><kwd id="jcmm70617-kwd-0003">matrine</kwd><kwd id="jcmm70617-kwd-0004">Wnt3a</kwd><kwd id="jcmm70617-kwd-0005">&#x003b2;&#x02010;Catenin</kwd></kwd-group><funding-group><award-group id="funding-0001"><funding-source>Shenyang Science and Technology Project</funding-source><award-id>22&#x02010;321&#x02010;33&#x02010;36</award-id></award-group><award-group id="funding-0002"><funding-source><institution-wrap><institution>National Natural Science Foundation of China
</institution><institution-id institution-id-type="doi">10.13039/501100001809</institution-id></institution-wrap></funding-source><award-id>82170328</award-id></award-group><award-group id="funding-0003"><funding-source><institution-wrap><institution>Liaoning Revitalization Talents Program
</institution><institution-id institution-id-type="doi">10.13039/501100018617</institution-id></institution-wrap></funding-source><award-id>XLYC2203006</award-id></award-group><award-group id="funding-0004"><funding-source><institution-wrap><institution>Natural Science Foundation of Liaoning Province
</institution><institution-id institution-id-type="doi">10.13039/501100005047</institution-id></institution-wrap></funding-source><award-id>2023&#x02010;MSLH&#x02010;349</award-id></award-group></funding-group><counts><fig-count count="7"/><table-count count="0"/><page-count count="16"/><word-count count="8300"/></counts><custom-meta-group><custom-meta><meta-name>source-schema-version-number</meta-name><meta-value>2.0</meta-value></custom-meta><custom-meta><meta-name>cover-date</meta-name><meta-value>May 2025</meta-value></custom-meta><custom-meta><meta-name>details-of-publishers-convertor</meta-name><meta-value>Converter:WILEY_ML3GV2_TO_JATSPMC version:6.5.6 mode:remove_FC converted:23.05.2025</meta-value></custom-meta></custom-meta-group></article-meta><notes><fn-group id="jcmm70617-ntgp-0001"><fn fn-type="funding" id="jcmm70617-note-0001"><p>
<bold>Funding:</bold> This study is supported by the funds from the National Natural Science Foundation of China (82170328), the LiaoNing Revitalization Talents Program (XLYC2203006), Shenyang Science and Technology Project (22&#x02010;321&#x02010;33&#x02010;36) and the Natural Science Foundation of Liaoning Province (2023&#x02010;MSLH&#x02010;349).</p></fn><fn fn-type="equal" id="jcmm70617-note-0002"><p>Guoxin Zhang and Xue Dong contributed equally to this study.</p></fn></fn-group></notes></front><body id="jcmm70617-body-0001"><def-list list-content="abbreviations" id="jcmm70617-dl-0001"><title>Abbreviations</title><def-item><term id="jcmm70617-li-0001">AF</term><def id="jcmm70617-li-0002"><p>atrial fibrillation</p></def></def-item><def-item><term id="jcmm70617-li-0003">BCA</term><def id="jcmm70617-li-0004"><p>bicinchoninic acid</p></def></def-item><def-item><term id="jcmm70617-li-0005">BP</term><def id="jcmm70617-li-0006"><p>biological process</p></def></def-item><def-item><term id="jcmm70617-li-0007">BSA</term><def id="jcmm70617-li-0008"><p>bovine serum albumin</p></def></def-item><def-item><term id="jcmm70617-li-0009">COL1A1</term><def id="jcmm70617-li-0010"><p>collagen I</p></def></def-item><def-item><term id="jcmm70617-li-0011">COL3A1</term><def id="jcmm70617-li-0012"><p>collagen III</p></def></def-item><def-item><term id="jcmm70617-li-0013">Cx40</term><def id="jcmm70617-li-0014"><p>connexin&#x02010;40</p></def></def-item><def-item><term id="jcmm70617-li-0015">Cx43</term><def id="jcmm70617-li-0016"><p>connexin&#x02010;43</p></def></def-item><def-item><term id="jcmm70617-li-0017">DEGs</term><def id="jcmm70617-li-0018"><p>differentially expressed genes</p></def></def-item><def-item><term id="jcmm70617-li-0019">Dvl</term><def id="jcmm70617-li-0020"><p>Dishevelled</p></def></def-item><def-item><term id="jcmm70617-li-0021">ECGs</term><def id="jcmm70617-li-0022"><p>electrocardiograms</p></def></def-item><def-item><term id="jcmm70617-li-0023">GO</term><def id="jcmm70617-li-0024"><p>gene ontology</p></def></def-item><def-item><term id="jcmm70617-li-0025">GSEA</term><def id="jcmm70617-li-0026"><p>gene set enrichment analysis</p></def></def-item><def-item><term id="jcmm70617-li-0027">GSK3&#x003b2;</term><def id="jcmm70617-li-0028"><p>glycogen synthetase 3&#x003b2;</p></def></def-item><def-item><term id="jcmm70617-li-0029">HF</term><def id="jcmm70617-li-0030"><p>heart failure</p></def></def-item><def-item><term id="jcmm70617-li-0031">IL&#x02010;1&#x003b2;</term><def id="jcmm70617-li-0032"><p>interleukin&#x02010;1&#x003b2;</p></def></def-item><def-item><term id="jcmm70617-li-0033">IL&#x02010;6</term><def id="jcmm70617-li-0034"><p>interleukin&#x02010;6</p></def></def-item><def-item><term id="jcmm70617-li-0035">KEGG</term><def id="jcmm70617-li-0036"><p>Kyoto Encyclopedia of Genes and Genomes</p></def></def-item><def-item><term id="jcmm70617-li-0037">LA</term><def id="jcmm70617-li-0038"><p>left atrial</p></def></def-item><def-item><term id="jcmm70617-li-0039">LVEF</term><def id="jcmm70617-li-0040"><p>left ventricular ejection fraction</p></def></def-item><def-item><term id="jcmm70617-li-0041">LVFS</term><def id="jcmm70617-li-0042"><p>left ventricular fractional shortening</p></def></def-item><def-item><term id="jcmm70617-li-0043">LVIDd</term><def id="jcmm70617-li-0044"><p>left ventricular internal diameter at end&#x02010;diastolic</p></def></def-item><def-item><term id="jcmm70617-li-0045">LVIDs</term><def id="jcmm70617-li-0046"><p>left ventricular internal diameter at end&#x02010;systolic</p></def></def-item><def-item><term id="jcmm70617-li-0047">LVPWd</term><def id="jcmm70617-li-0048"><p>left ventricular posterior wall diameter</p></def></def-item><def-item><term id="jcmm70617-li-0049">MAT</term><def id="jcmm70617-li-0050"><p>matrine</p></def></def-item><def-item><term id="jcmm70617-li-0051">MMP2</term><def id="jcmm70617-li-0052"><p>matrix metallopeptidase 2</p></def></def-item><def-item><term id="jcmm70617-li-0053">MMP9</term><def id="jcmm70617-li-0054"><p>matrix metallopeptidase 9</p></def></def-item><def-item><term id="jcmm70617-li-0055">PPI</term><def id="jcmm70617-li-0056"><p>protein&#x02013;protein interaction</p></def></def-item><def-item><term id="jcmm70617-li-0057">SDS&#x02010;PAGE</term><def id="jcmm70617-li-0058"><p>sodium dodecyl sulphate&#x02010;polyacrylamide</p></def></def-item><def-item><term id="jcmm70617-li-0059">TAC</term><def id="jcmm70617-li-0060"><p>transversal aortic contraction</p></def></def-item><def-item><term id="jcmm70617-li-0061">TGF&#x02010;&#x003b2;</term><def id="jcmm70617-li-0062"><p>transforming growth factor &#x003b2;</p></def></def-item><def-item><term id="jcmm70617-li-0063">TNF&#x02010;&#x003b1;</term><def id="jcmm70617-li-0064"><p>tumour necrosis factor &#x003b1;</p></def></def-item><def-item><term id="jcmm70617-li-0065">WGA</term><def id="jcmm70617-li-0066"><p>wheat germ agglutinin</p></def></def-item><def-item><term id="jcmm70617-li-0067">&#x003b1;&#x02010;SMA</term><def id="jcmm70617-li-0068"><p>&#x003b1;&#x02010;smooth muscle actin</p></def></def-item></def-list><sec id="jcmm70617-sec-0001"><label>1</label><title>Introduction</title><p>Despite extensive efforts to comprehend its pathophysiology and develop effective treatments, the incidence of atrial fibrillation (AF) continues to rise annually [<xref rid="jcmm70617-bib-0001" ref-type="bibr">1</xref>]. Epidemiological studies have established a close association between AF and factors such as hypertension, diabetes and heart failure (HF) [<xref rid="jcmm70617-bib-0002" ref-type="bibr">2</xref>]. The occurrence of AF exhibits an intricate association with atrial structure and electrophysiological remodelling [<xref rid="jcmm70617-bib-0003" ref-type="bibr">3</xref>]. In a clinical study, researchers observed that patients with persistent AF exhibited elevated left atrial (LA) pressure, leading to structural remodelling of the atria and significantly augmenting the complexity associated with treating AF [<xref rid="jcmm70617-bib-0004" ref-type="bibr">4</xref>]. However, there are limited therapeutic approaches against AF associated with pressure overload.</p><p>The Wnt signalling pathway is highly conserved throughout evolution and plays a pivotal role in diverse biological species [<xref rid="jcmm70617-bib-0005" ref-type="bibr">5</xref>]. Wnt signalling pathways can be categorised into typical and atypical pathways. The canonical Wnt pathway relies on &#x003b2;&#x02010;catenin&#x02010;mediated transcription of downstream target genes, whereas the non&#x02010;canonical Wnt pathways are &#x003b2;&#x02010;catenin independent and encompass calcium&#x02010;dependent (Wnt/Ca<sup>2+</sup>) pathways as well as planar cell polarity (Wnt/PCP) pathways [<xref rid="jcmm70617-bib-0006" ref-type="bibr">6</xref>]. In the normal adult heart, Wnt signalling remains quiescent. However, during heart injury&#x02010;induced remodelling, Wnt signalling is reactivated, thereby promoting tissue fibrosis and inflammatory changes [<xref rid="jcmm70617-bib-0007" ref-type="bibr">7</xref>]. Several studies have reported that Wnt/&#x003b2;&#x02010;catenin signalling not only promotes fibroblast aggregation but also exhibits synergistic effects with TGF&#x02010;&#x003b2; [<xref rid="jcmm70617-bib-0008" ref-type="bibr">8</xref>, <xref rid="jcmm70617-bib-0009" ref-type="bibr">9</xref>]. Furthermore, through crosstalk with NF&#x02010;&#x003ba;B, Wnt/&#x003b2;&#x02010;catenin signalling enhances the production of pro&#x02010;inflammatory cytokines [<xref rid="jcmm70617-bib-0010" ref-type="bibr">10</xref>]. The Wnt3a protein is widely recognised as a prototypical signalling molecule within the Wnt family. The research findings indicate that activation of the Wnt3a/&#x003b2;&#x02010;catenin signalling pathway exerts a profound influence on atrial fibroblast transforming into myofibroblasts [<xref rid="jcmm70617-bib-0011" ref-type="bibr">11</xref>]. Nonetheless, the precise role of the Wnt3a/&#x003b2;&#x02010;catenin signalling pathway in pressure overload&#x02010;associated AF remains elusive.</p><p>Matrine (MAT, C<sub>15</sub>H<sub>24</sub>N<sub>2</sub>O) is a significant quinolizidine alkaloid derived from the roots of the traditional Chinese herb <styled-content style="fixed-case" toggle="no">
<italic toggle="no">Sophora flavescens</italic>
</styled-content>. Studies have demonstrated that MAT possesses anti&#x02010;inflammatory, anti&#x02010;fibrotic and antioxidant properties, which can aid in the prevention and treatment of a variety of cardiovascular diseases [<xref rid="jcmm70617-bib-0012" ref-type="bibr">12</xref>]. Previous research has demonstrated that MAT can effectively prevent myocardial hypertrophy and interstitial fibrosis induced by pressure overload following abdominal aortic coarctation in rats [<xref rid="jcmm70617-bib-0013" ref-type="bibr">13</xref>]. Notably, recent studies have revealed that MAT can inhibit cardiac remodelling and pathological fibrosis through the regulation of the RPS5/p38 signalling pathway, potentially benefiting the prevention and treatment of heart failure and arrhythmia [<xref rid="jcmm70617-bib-0014" ref-type="bibr">14</xref>]. Furthermore, Zhou et&#x000a0;al. highlighted its potential as an anti&#x02010;arrhythmic agent by elucidating its impact on atrial ion channels in mice [<xref rid="jcmm70617-bib-0015" ref-type="bibr">15</xref>]. Nevertheless, the influence of MAT on pressure overload&#x02010;associated atrial remodelling and the progression of AF remains to be elucidated.</p><p>The objective of this study was to examine the potential role of canonical Wnt signalling in pressure overload&#x02010;induced AF and atrial remodelling and to further explore the impact of MAT treatment.</p></sec><sec sec-type="materials-and-methods" id="jcmm70617-sec-0002"><label>2</label><title>Materials and Methods</title><sec id="jcmm70617-sec-0003"><label>2.1</label><title>
<styled-content style="fixed-case" toggle="no">RNA</styled-content> Sequencing and Data Analysis</title><p>RNA sequencing was conducted according to the protocols described in our previous publications [<xref rid="jcmm70617-bib-0016" ref-type="bibr">16</xref>, <xref rid="jcmm70617-bib-0017" ref-type="bibr">17</xref>]. Briefly, the mice were humanely euthanised, after which the atrial samples were immediately excised and rinsed. Total RNA was extracted, and an RNA library was prepared. The resulting libraries were then sequenced on the Illumina NovaSeq X system (Berry Genomics, Beijing, China). The differentially expressed genes (DEGs) were screened by R software (2023.06.0 Build 421). Genes with a <italic toggle="yes">p</italic>&#x02010;value &#x0003c;&#x02009;0.05 and absolute Log fold change (LogFC)&#x02009;&#x0003e;&#x02009;0.585 were considered differentially expressed between the Sham and TAC groups. For comparison between the TAC and TAC&#x02009;+&#x02009;MAT groups, a less stringent threshold of |LogFC|&#x02009;&#x0003e;&#x02009;0.263 was applied to detect subtle changes. Visualisation of the heatmap was accomplished with TBtools&#x02010;II software (v2.119). The Gene Ontology (GO) enrichment analysis was carried out via the Metascape bioinformatics tool (<ext-link xlink:href="http://metascape.org" ext-link-type="uri">http://metascape.org</ext-link>, v3.5.20240101), and the findings were graphically represented using the SRplot platform [<xref rid="jcmm70617-bib-0018" ref-type="bibr">18</xref>].</p></sec><sec id="jcmm70617-sec-0004"><label>2.2</label><title>Network Construction</title><p>The targets for MAT were retrieved from the TCMSP (<ext-link xlink:href="https://old.tcmsp-e.com/tcmsp.php" ext-link-type="uri">https://old.tcmsp&#x02010;e.com/tcmsp.php</ext-link>) and PharmMapper (<ext-link xlink:href="http://lilab-ecust.cn/pharmmapper/" ext-link-type="uri">http://lilab&#x02010;ecust.cn/pharmmapper/</ext-link>) databases. Subsequently, the UniProt database (<ext-link xlink:href="https://www.uniprot.org/" ext-link-type="uri">https://www.uniprot.org/</ext-link>) was utilised to standardise these targets. A keyword search for &#x0201c;atrial fibrillation&#x0201d; was conducted in GeneCards, OMIM and DrugBank databases to identify associated targets. Subsequently, a Venn diagram was constructed to screen targets for MAT intervention in AF. To establish a protein&#x02013;protein interaction (PPI) network among these intersecting targets, STRING (<ext-link xlink:href="https://string-db.org/" ext-link-type="uri">https://string&#x02010;db.org/</ext-link>) was employed. Furthermore, Cytoscape 3.9.1 software was utilised to extract core targets and construct an &#x0201c;active ingredient&#x02010;target&#x02010;pathway&#x0201d; network. Topological analysis using the Network Analysis function provided degree value information.</p></sec><sec id="jcmm70617-sec-0005"><label>2.3</label><title>Human Atrial Samples</title><p>Right atrial tissue samples were collected from 12 male patients diagnosed with valvular heart disease, with 6 of them presenting with AF. The demographic characteristics of these patients are detailed in Table&#x000a0;<xref rid="jcmm70617-supitem-0002" ref-type="supplementary-material">S1</xref>. Exclusion criteria included individuals over the age of 70, severe infectious diseases, significant hepatic or renal impairment and malignant neoplasms. Prior to enrolment, all participants underwent a 12&#x02010;lead electrocardiogram and were categorised into either sinus rhythm or atrial fibrillation groups. Informed consent was obtained from each patient. All experimental protocols were approved by the Clinical Medical Research Ethics Committee of the Northern Theatre General Hospital (No. 2023&#x02010;005) and were performed in accordance with the Declaration of Helsinki.</p></sec><sec id="jcmm70617-sec-0006"><label>2.4</label><title>Animals and Treatments</title><p>This study strictly adhered to the Institutional Animal Care and Use Guidelines and received approval from the Ethics Committee of the General Hospital of the Northern Theatre Command (No. 2024&#x02010;05). Male C57/BL6 mice (9&#x02009;weeks of age) obtained from Huafukang Biotechnology Co., LTD (Beijing, China) were fed normal food and water for 1&#x02009;week prior to the experiment. The study was conducted in two sequential phases. In the first phase, mice were randomly assigned to four groups (15 animals per group): Sham group, TAC group, TAC&#x02009;+&#x02009;50&#x02009;mg/kg MAT group (TAC&#x02009;+&#x02009;L&#x02010;MAT) and TAC&#x02009;+&#x02009;100&#x02009;mg/kg MAT group (TAC&#x02009;+&#x02009;H&#x02010;MAT). The dose of MAT used in the second phase was determined based on the optimal dose identified in the first phase of the experiment. In the second phase, mice were randomly divided into five groups (15 animals per group): Sham group, TAC group, TAC&#x02009;+&#x02009;10&#x02009;mg/kg SKL2001 group (TAC&#x02009;+&#x02009;SKL2001), TAC&#x02009;+&#x02009;MAT group (TAC&#x02009;+&#x02009;MAT) and TAC&#x02009;+&#x02009;10&#x02009;mg/kg SKL2001&#x02009;+&#x02009;MAT group (TAC&#x02009;+&#x02009;SKL2001&#x02009;+&#x02009;MAT). A TAC model was constructed using the previously described method [<xref rid="jcmm70617-bib-0019" ref-type="bibr">19</xref>]. Briefly, tracheal intubation was performed under 1%&#x02013;2% isoflurane anaesthesia. After a midline sternotomy, a 6&#x02013;0 silk suture was secured around a 27&#x02010;gauge needle positioned near the aorta distal to the brachiocephalic artery. Finally, the sternum and skin were closed. Animals in the sham surgery group underwent a similar procedure without TAC induction (Figures&#x000a0;<xref rid="jcmm70617-fig-0002" ref-type="fig">2A</xref> and <xref rid="jcmm70617-fig-0005" ref-type="fig">5A</xref>). MAT (purity &#x0003e;&#x02009;98%) was purchased from MCE biotechnology (#HY&#x02010;N0164). The dose of MAT and SKL2001 was chosen based on the preliminary experiment and previous publication [<xref rid="jcmm70617-bib-0020" ref-type="bibr">20</xref>, <xref rid="jcmm70617-bib-0021" ref-type="bibr">21</xref>]. Mice in the Sham and TAC groups were administered equal volumes of water via intragastric delivery for a duration of 4&#x02009;weeks.</p></sec><sec id="jcmm70617-sec-0007"><label>2.5</label><title>Echocardiography</title><p>In accordance with the methodology outlined in our previous study [<xref rid="jcmm70617-bib-0022" ref-type="bibr">22</xref>], the left cardiac system in mice was assessed using a Doppler ultrasound imaging system (D700, VINNO, Suzhou, China). Briefly, following anaesthesia administration, the mice were placed in a supine position for the assessment of left cardiac function through the recording of parasternal long&#x02010;axis movement. Dedicated software was then employed to compute various parameters, including left ventricular posterior wall diameter (LVPWd), left ventricular end&#x02010;diastolic diameter (LVIDd), left ventricular ejection fraction (LVEF), left ventricular fractional shortening (LVFS), left atrial diameter (LAD) and left atrial area.</p></sec><sec id="jcmm70617-sec-0008"><label>2.6</label><title>Programmed Intracardiac Stimulation</title><p>To investigate the susceptibility to AF, we conducted cardiac burst pacing using a methodology described in our previous study [<xref rid="jcmm70617-bib-0023" ref-type="bibr">23</xref>]. Briefly, the mice were placed in a supine position and anaesthetised. The 1&#x02010;1&#x02010;French octupole catheter (Transonic Scisense Inc., Ontario, Canada) was inserted into the right atrium via the right jugular vein and connected to the RA&#x02010;834 recorder (iWorx System Inc., Dover, NH, USA). PowerLab monitoring system and LabChart v7 software (ADInstruments, Castle Hill, Australia) were used to observe the cardiac activity of mice. Atrial arrhythmias were induced by 25&#x02009;Hz 3&#x02010;s burst pacing. AF is defined as a rapid or irregular atrial rhythm that lasts at least 1&#x02009;s. Successful AF induction necessitated at least two rapid pacings within three consecutive stimuli.</p></sec><sec id="jcmm70617-sec-0009"><label>2.7</label><title>Electrophysiological Mapping</title><p>The electrophysiological mapping of the left atrium was conducted in accordance with our previously described methodology [<xref rid="jcmm70617-bib-0016" ref-type="bibr">16</xref>, <xref rid="jcmm70617-bib-0022" ref-type="bibr">22</xref>, <xref rid="jcmm70617-bib-0024" ref-type="bibr">24</xref>]. In brief, the mice were euthanised under anaesthesia, and their hearts were subsequently excised. The mice's hearts were cannulated through the aorta and connected to the Langendorff system, with Tyrode's solution perfused at a constant temperature of 37.0&#x000b0;C and a flow rate of 2&#x02013;5&#x02009;mL/min. Epicardial conduction signals were recorded using a multi&#x02010;electrode array consisting of a 64&#x02010;channel multi&#x02010;electrode array (MappingLab Ltd., Oxford, UK) placed on the surface of the left atrium while data acquisition was performed utilising EMapRecord software 5.0 (MappingLab Ltd., Oxford, UK). Subsequently, EMapScope software 5.0 (MappingLab Ltd., Oxford, UK) was employed for analysing parameters including average conduction velocity as well as absolute and relative inhomogeneity indices for each experimental group.</p></sec><sec id="jcmm70617-sec-0010"><label>2.8</label><title>Masson's Trichrome Staining</title><p>Masson's trichrome staining was performed as described previously [<xref rid="jcmm70617-bib-0024" ref-type="bibr">24</xref>]. The hearts of mice in each group were fixed overnight in a 4% paraformaldehyde solution (pH&#x02009;7.2, 158,127, Sigma&#x02010;Aldrich, USA), followed by dehydration and embedding in paraffin. Subsequently, the paraffin&#x02010;embedded samples were sectioned into 6&#x02009;&#x003bc;m slices and stained with Masson's trichrome according to the manufacturer's protocol (abs9348, Absin, Shanghai, China). The fibrotic area was quantified for each section using Image&#x02010;Pro Plus 6.0 (Media Cybernetics, USA).</p></sec><sec id="jcmm70617-sec-0011"><label>2.9</label><title>Immunofluorescence Staining</title><p>Immunofluorescence staining was employed to assess the expressions of atrial connexin 40 (Cx40), connexin 43 (Cx43), &#x003b1;&#x02010;SMA, Wnt3a and active &#x003b2;&#x02010;catenin as described previously [<xref rid="jcmm70617-bib-0016" ref-type="bibr">16</xref>]. Atrial tissue sections were prepared at a thickness of 5&#x02009;&#x003bc;m and treated with 0.2% Triton X&#x02010;100 for 15&#x02009;min followed by blocking (10% BSA, 37&#x000b0;C, 1.5&#x02009;h). Subsequently, the tissue sections were incubated overnight at 4&#x000b0;C with the specified primary antibody. Information on the primary antibodies used was listed in Table&#x000a0;<xref rid="jcmm70617-supitem-0003" ref-type="supplementary-material">S2</xref>. Nuclei were stained with DAPI (Beyotime Biotechnology, Shanghai, China) for 10&#x02009;min, and cell membranes were stained with wheat germ agglutinin (WGA, 10&#x02009;&#x003bc;g/mL, W11261, Invitrogen, Carlsbad, CA, USA). Fluorescence levels were subsequently captured using a Nikon C2 Plus confocal microscope (Nikon, Tokyo, Japan). The resulting images were analysed using ImageJ software.</p></sec><sec id="jcmm70617-sec-0012"><label>2.10</label><title>Cytoplasmic and Nuclear Protein Extraction and Western Blot Analysis</title><p>Western blot experiment was conducted as described in the previous report [<xref rid="jcmm70617-bib-0017" ref-type="bibr">17</xref>]. Cytoplasmic and nucleoprotein extraction was conducted using a commercial kit (P0028, Beyotime Biotechnology, Shanghai, China) following the manufacturer's instructions. The protein from mice atrial tissue was extracted, and the protein concentration was determined using the BCA protein concentration detection kit (P0010S, Beyotime Biotechnology, Shanghai, China). Then, the protein samples were separated by 8%&#x02013;12% SDS&#x02010;PAGE and subsequently transferred onto PVDF membranes for western blotting. The membranes were sealed with 5% skim milk (A600669, Sangon Biotech, Shanghai, China) for a duration of 2&#x02009;h, followed by an overnight incubation at 4&#x000b0;C with the primary antibody. Information on the primary antibodies used was listed in Table&#x000a0;<xref rid="jcmm70617-supitem-0003" ref-type="supplementary-material">S2</xref>. The membranes were subsequently washed and incubated with a horseradish peroxidase&#x02010;conjugated secondary antibody at ambient temperature for a duration of 2&#x02009;h. Imprints were detected through enhanced chemiluminescence and scanned using a chemiluminescence system (Tanon Technology, Shanghai, China). The obtained images were analysed with Image J software (Table&#x000a0;<xref rid="jcmm70617-supitem-0004" ref-type="supplementary-material">S3</xref>).</p></sec><sec id="jcmm70617-sec-0013"><label>2.11</label><title>Data Analysis and Statistics</title><p>The data were analysed using GraphPad Prism software (Version 9.0, San Diego, CA, USA) and presented as mean&#x02009;&#x000b1;&#x02009;SEM. Student's <italic toggle="yes">t</italic>&#x02010;test was used to compare the two groups. Groups were compared using an unpaired 2&#x02010;tailed <italic toggle="yes">t</italic>&#x02010;test, one&#x02010;way or two&#x02010;way ANOVA with Bonferroni post hoc test [<xref rid="jcmm70617-bib-0025" ref-type="bibr">25</xref>]. AF durations were assessed using a Mann&#x02013;Whitney <italic toggle="yes">U</italic> test with Dunn's multiple comparison test as the data were not normally distributed (D'Agostino and Pearson omnibus normality test). To analyse the data of AF inducibility, the Fisher exact test was employed [<xref rid="jcmm70617-bib-0026" ref-type="bibr">26</xref>]. Statistical significance was defined as <italic toggle="yes">p</italic>&#x02009;&#x0003c;&#x02009;0.05.</p></sec></sec><sec sec-type="results" id="jcmm70617-sec-0014"><label>3</label><title>Results</title><sec id="jcmm70617-sec-0015"><label>3.1</label><title>Bioinformatics Analysis and Clinical Evidence Revealed the Potential Involvement of Canonical Wnt Signalling in the Pathogenesis of <styled-content style="fixed-case" toggle="no">AF</styled-content>
</title><p>To elucidate the potential mechanisms underlying AF genesis, we performed bulk RNA sequencing followed by GO analysis on atrial tissue samples obtained from mice. Here, 556 DEGs were identified with 297 up&#x02010;regulated and 259 down&#x02010;regulated (Figure&#x000a0;<xref rid="jcmm70617-fig-0001" ref-type="fig">1A</xref>). Subsequent GO analysis revealed that the up&#x02010;regulated DEGs were mainly enriched in extracellular matrix organisation, cardiac atrium morphogenesis, cardiac myofibril assembly, atrial cardiac muscle tissue development and, importantly, regulation of the canonical Wnt signalling pathway (Figure&#x000a0;<xref rid="jcmm70617-fig-0001" ref-type="fig">1B</xref>). These data suggested that the abnormality of extracellular matrix organisation, inflammatory response and, critically, aberrant regulation of the canonical Wnt signalling pathway might contribute to TAC surgery&#x02010;associated AF. The Wnt3a&#x02010;mediated canonical Wnt pathway within the Wnt family has been extensively investigated in cardiovascular disease. The Wnt3a/&#x003b2;&#x02010;catenin signalling pathway plays a pivotal role in cardiac remodelling, cardiac fibrosis and apoptosis [<xref rid="jcmm70617-bib-0027" ref-type="bibr">27</xref>, <xref rid="jcmm70617-bib-0028" ref-type="bibr">28</xref>]. Therefore, we further validated the aforementioned findings using human right atrial appendage tissue samples. Western blot analysis revealed significant up&#x02010;regulated atrial Wnt3a and the downstream Wnt signalling molecules (Figure&#x000a0;<xref rid="jcmm70617-fig-0001" ref-type="fig">1C,D</xref>). Taken together, these data indicate that Wnt3a and the canonical Wnt pathway are possibly involved in TAC&#x02010;induced atrial damage.</p><fig position="float" fig-type="FIGURE" id="jcmm70617-fig-0001"><label>FIGURE 1</label><caption><p>Activation of the Wnt3a/&#x003b2;&#x02010;catenin signalling pathway in the atrial tissue of patients diagnosed with AF. (A) Heatmap showing 297 up&#x02010;regulated and 256 down&#x02010;regulated DEGs in the TAC group versus the Sham group. (B) GO enrichment results including BP (<italic toggle="yes">n</italic>&#x02009;=&#x02009;5). (C, D) Representative western blot images and relative atrial expression of Wnt3a, p&#x02010;GSK3&#x003b2;, active &#x003b2;&#x02010;catenin, &#x003b2;&#x02010;catenin (<italic toggle="yes">n</italic>&#x02009;=&#x02009;6). Data were expressed as mean&#x02009;&#x000b1;&#x02009;SEM. **<italic toggle="yes">p</italic>&#x02009;&#x0003c;&#x02009;0.01, ***<italic toggle="yes">p</italic>&#x02009;&#x0003c;&#x02009;0.001.</p></caption><graphic xlink:href="JCMM-29-e70617-g006" position="anchor" id="jats-graphic-1"/></fig></sec><sec id="jcmm70617-sec-0016"><label>3.2</label><title>
<styled-content style="fixed-case" toggle="no">MAT</styled-content> Ameliorated Stress Overload&#x02010;Induced Cardiac Dysfunction, Atrial Dilatation and Atrial Fibrosis in Mice</title><p>To assess the impact of MAT on cardiac function and atrial structure in TAC&#x02010;injured mice, echocardiographic analysis was conducted. The results indicated that the TAC&#x02010;induced mice group displayed heart enlargement and impaired cardiac function. However, these adverse effects were mitigated following MAT intervention (Figure&#x000a0;<xref rid="jcmm70617-fig-0002" ref-type="fig">2B&#x02013;H</xref>). Moreover, Masson's trichromatic staining revealed a significant reduction in atrial fibrosis after MAT intervention, showing a dose&#x02010;dependent pattern (Figure&#x000a0;<xref rid="jcmm70617-fig-0002" ref-type="fig">2I,J</xref>). Additionally, to assess the potential therapeutic effects of MAT therapy on atrial fibrosis in TAC mice, we quantified the expression levels of COL1A1, COL3A1 and &#x003b1;&#x02010;SMA protein in atrial tissue. Western blot analysis (Figure&#x000a0;<xref rid="jcmm70617-fig-0002" ref-type="fig">2K&#x02013;N</xref>) and immunofluorescence staining (Figure&#x000a0;<xref rid="jcmm70617-fig-0002" ref-type="fig">2O,P</xref>) demonstrated a notable decrease in COL1A1, COL3A1 and &#x003b1;&#x02010;SMA levels, as well as &#x003b1;&#x02010;SMA fluorescence intensity, following MAT intervention compared to the TAC group. These results indicate that MAT exerts a significant inhibitory effect on TAC&#x02010;induced cardiac dysfunction and atrial remodelling in mice.</p><fig position="float" fig-type="FIGURE" id="jcmm70617-fig-0002"><label>FIGURE 2</label><caption><p>Potential of MAT to ameliorate atrial remodelling and mitigate tissue fibrosis induced by TAC. (A) Grouping of experimental animals and schematic diagram of the experiment. (B) Representative echocardiographic images of the atria and ventricle. (C&#x02013;H) Echocardiographic parameters including left ventricular ejection fraction (LVEF), left ventricular shortening fraction (LVFS), left ventricular end&#x02010;diastolic diameter (LVIDd), left ventricular posterior wall diameter (LVPWd), left atrial diameter (LAD) and left atrial diastolic area (<italic toggle="yes">n</italic>&#x02009;=&#x02009;5). (I) Overall cardiac morphology and representative Masson's trichromatic staining images (upper bar&#x02009;=&#x02009;2&#x02009;mm, lower bar&#x02009;=&#x02009;100&#x02009;&#x003bc;m). (J) Percentage of the total area with fibrosis (<italic toggle="yes">n</italic>&#x02009;=&#x02009;5). (K&#x02013;N) Representative western blot images and relative expression of COL1A1, COL3A1 and &#x003b1;&#x02010;SMA in each group of atria (<italic toggle="yes">n</italic>&#x02009;=&#x02009;4). (O, P) Relative immunofluorescence intensity of &#x003b1;&#x02010;SMA (<italic toggle="yes">n</italic>&#x02009;=&#x02009;4). Data were expressed as mean&#x02009;&#x000b1;&#x02009;SEM. ***<italic toggle="yes">p</italic>&#x02009;&#x0003c;&#x02009;0.001, versus Sham group; <sup>#</sup>
<italic toggle="yes">p</italic>&#x02009;&#x0003c;&#x02009;0.05, <sup>##</sup>
<italic toggle="yes">p</italic>&#x02009;&#x0003c;&#x02009;0.01, <sup>###</sup>
<italic toggle="yes">p</italic>&#x02009;&#x0003c;&#x02009;0.001, versus TAC group.</p></caption><graphic xlink:href="JCMM-29-e70617-g002" position="anchor" id="jats-graphic-3"/></fig></sec><sec id="jcmm70617-sec-0017"><label>3.3</label><title>
<styled-content style="fixed-case" toggle="no">MAT</styled-content> Attenuated Stress Overload&#x02010;Induced Atrial Electrical Remodelling and Connexin Remodelling in Mice</title><p>Subsequently, we examined the effects of MAT on atrial electrical remodelling in mouse models induced by TAC. In the TAC group, the susceptibility to AF was markedly enhanced, and the duration of AF episodes was significantly prolonged. However, after MAT intervention, both the incidence and duration of AF were substantially reduced (Figure&#x000a0;<xref rid="jcmm70617-fig-0003" ref-type="fig">3A&#x02013;C</xref>). Furthermore, the results from the Langendorff cardiac perfusion system demonstrated that, compared to the Sham group, the atrial electrical conduction velocity was reduced, conduction heterogeneity was enhanced and the heterogeneity index was elevated in the TAC group. Notably, administration of MAT improved both atrial electrical conduction velocity and homogeneity indices (Figure&#x000a0;<xref rid="jcmm70617-fig-0003" ref-type="fig">3D&#x02013;G</xref>). Connexins are gap junction channels crucial for maintaining the electrophysiological functions of cardiomyocytes. We analysed Cx40 and Cx43 levels in atrial tissues through western blot analysis (Figure&#x000a0;<xref rid="jcmm70617-fig-0003" ref-type="fig">3H&#x02013;J</xref>) and immunofluorescence staining (Figure&#x000a0;<xref rid="jcmm70617-fig-0003" ref-type="fig">3K&#x02013;M</xref>), revealing enhanced connexin expression following MAT intervention, particularly with high concentrations. These findings suggest that TAC&#x02010;induced atrial electrical remodelling heightens susceptibility to AF, whereas MAT attenuates such remodelling and reduces vulnerability to AF.</p><fig position="float" fig-type="FIGURE" id="jcmm70617-fig-0003"><label>FIGURE 3</label><caption><p>Potential of MAT to ameliorate atrial remodelling induced by TAC. (A) Representative ECG traces following burst pacing in the right atrium. The dashed line represents the atrial fibrillation rhythm. (B, C) Summary of AF induction and AF duration in each group (<italic toggle="yes">n</italic>&#x02009;=&#x02009;8). (D) Langendorff electrophysiological mapping images. The bars represent the duration from the initial to the final measurement within one heartbeat (<italic toggle="yes">n</italic>&#x02009;=&#x02009;5). (E&#x02013;G) Summary of left atrial activation patterns. EMapScope 5.0 software was used to calculate the mean conduction velocity, absolute inhomogeneity and inhomogeneity index of the left atrium (<italic toggle="yes">n</italic>&#x02009;=&#x02009;5). (H&#x02013;J) Representative western blot images and relative atrial expression of Cx40 and Cx43 (<italic toggle="yes">n</italic>&#x02009;=&#x02009;4). (K&#x02013;M) WGA (green), Cx40 and Cx43 (red) and DAPI (blue) immunofluorescence stain representation and Cx40 and Cx43 relative immunofluorescence intensity (<italic toggle="yes">n</italic>&#x02009;=&#x02009;4). Data were expressed as mean&#x02009;&#x000b1;&#x02009;SEM. ***<italic toggle="yes">p</italic>&#x02009;&#x0003c;&#x02009;0.001, versus Sham group; <sup>ns</sup>
<italic toggle="yes">p</italic>&#x02009;&#x0003e;&#x02009;0.05, <sup>#</sup>
<italic toggle="yes">p</italic>&#x02009;&#x0003c;&#x02009;0.05, <sup>##</sup>
<italic toggle="yes">p</italic>&#x02009;&#x0003c;&#x02009;0.01, <sup>###</sup>
<italic toggle="yes">p</italic>&#x02009;&#x0003c;&#x02009;0.001, versus TAC group.</p></caption><graphic xlink:href="JCMM-29-e70617-g005" position="anchor" id="jats-graphic-5"/></fig></sec><sec id="jcmm70617-sec-0018"><label>3.4</label><title>
<styled-content style="fixed-case" toggle="no">MAT</styled-content> Effectively Inhibited Wnt3a/&#x003b2;&#x02010;Catenin Signalling Pathway, Attenuated Atrial Inflammation and Alleviated Atrial Fibrosis</title><p>To identify potential targets for MAT treatment of AF, we systematically screened 117 potentially relevant targets (Figure&#x000a0;<xref rid="jcmm70617-fig-0004" ref-type="fig">4A</xref>). Through the analysis and screening of the obtained protein&#x02013;protein interaction (PPI) network, eight core targets were identified: ALB, IL&#x02010;6, TNF, PPARG, IGF1 and GSK3&#x003b2;. Among these, GSK3&#x003b2; serves as a critical negative regulator of the Wnt3a/&#x003b2;&#x02010;catenin pathway. Its activity status directly governs the stability of &#x003b2;&#x02010;catenin, thereby influencing the progression of myocardial fibrosis and electrical remodelling (Figure&#x000a0;<xref rid="jcmm70617-fig-0004" ref-type="fig">4B,C</xref>). To gain deeper insights into the pharmacological effects of MAT, we performed RNA sequencing on both the TAC&#x02010;induced injury group and the MAT&#x02010;treated group. The results were presented in Figure&#x000a0;<xref rid="jcmm70617-fig-0004" ref-type="fig">4D</xref>, showing a heatmap of 1299 DEGs. Next, we conducted further GO analysis and found that biological processes including regulation of inflammasome&#x02010;mediated signalling pathway, regulation of interleukin&#x02010;1 beta production, regulation of cardiac muscle cell contraction, regulation of interleukin&#x02010;6 production and negative regulation of the Wnt signalling pathway were enriched (Figure&#x000a0;<xref rid="jcmm70617-fig-0004" ref-type="fig">4E</xref>). Based on these findings, we further investigated the Wnt3a&#x02010;mediated canonical signalling pathway. Western blotting analysis (Figure&#x000a0;<xref rid="jcmm70617-fig-0004" ref-type="fig">4F&#x02013;J</xref>) revealed activation of this pathway in the TAC group, characterised by significantly increased levels of Wnt3a, active &#x003b2;&#x02010;catenin, &#x003b2;&#x02010;catenin and p&#x02010;GSK3&#x003b2; compared to the Sham group. Conversely, GSK3&#x003b2; levels were decreased (Figure&#x000a0;<xref rid="jcmm70617-fig-0004" ref-type="fig">4J</xref>). Immunofluorescence staining for Wnt3a and active &#x003b2;&#x02010;catenin yielded similar findings (Figure&#x000a0;<xref rid="jcmm70617-fig-0004" ref-type="fig">4K&#x02013;M</xref>). Quantification of active &#x003b2;&#x02010;catenin levels in both the nucleus and cytoplasm demonstrated a significantly higher abundance in the TAC group compared to the Sham group (Figure&#x000a0;<xref rid="jcmm70617-fig-0004" ref-type="fig">4N&#x02013;P</xref>). Notably, MAT dose&#x02010;dependently inhibited the Wnt3a/&#x003b2;&#x02010;catenin signalling pathway when compared to the TAC group. Furthermore, western blotting tests were conducted according to the results of network pharmacology and RNA sequencing analysis. The results showed that compared with the Sham group, the expression levels of TGF&#x02010;&#x003b2;, MMP2, MMP9, TNF&#x02010;&#x003b1;, IL&#x02010;1&#x003b2; and IL&#x02010;6 were all increased in the TAC group, which was reversed by MAT intervention (compared to the TAC group, Figure&#x000a0;<xref rid="jcmm70617-fig-0004" ref-type="fig">4Q&#x02013;W</xref>). These findings suggest that MAT may modulate TAC&#x02010;induced atrial fibrosis and inflammation through inhibition of the Wnt3a/&#x003b2;&#x02010;catenin signalling pathway.</p><fig position="float" fig-type="FIGURE" id="jcmm70617-fig-0004"><label>FIGURE 4</label><caption><p>Effects of MAT administration on Wnt3a/&#x003b2;&#x02010;catenin signalling and atrial inflammation and fibrosis in mice subjected to TAC. (A) Venn diagram of the Matrine targets and AF targets. (B, C) MAT component&#x02010;target&#x02010;pathway network diagram and the key targets screened out. (D) Heatmap showing 593 up&#x02010;regulated and 706 down&#x02010;regulated DEGs in the TAC&#x02009;+&#x02009;MAT group versus the TAC group. (E) GO enrichment results including BP, CC, MF (<italic toggle="yes">n</italic>&#x02009;=&#x02009;5). (F&#x02013;J) Representative western blot images and relative atrial expression of Wnt3a, p&#x02010;GSK3&#x003b2;, active &#x003b2;&#x02010;catenin and &#x003b2;&#x02010;catenin (<italic toggle="yes">n</italic>&#x02009;=&#x02009;4). (K&#x02013;M) &#x003b1;&#x02010;actinin/Vimentin (green), Wnt3a/active &#x003b2;&#x02010;catenin (red) and DAPI (blue) immunofluorescence stain representation and Wnt3a/active &#x003b2;&#x02010;catenin relative immunofluorescence intensity (<italic toggle="yes">n</italic>&#x02009;=&#x02009;4). (N&#x02013;P) Representative western blot images and quantification of active &#x003b2;&#x02010;catenin expression in the atrial nucleus or cytoplasm (<italic toggle="yes">n</italic>&#x02009;=&#x02009;4). (Q&#x02013;W) Representative western blot images and relative atrial expression of TNF&#x02010;&#x003b1;, IL&#x02010;1&#x003b2;, IL&#x02010;6, TGF&#x02010;&#x003b2;, MMP2 and MM9 (<italic toggle="yes">n</italic>&#x02009;=&#x02009;4). Data were expressed as mean&#x02009;&#x000b1;&#x02009;SEM. ***<italic toggle="yes">p</italic>&#x02009;&#x0003c;&#x02009;0.001, versus Sham group; <sup>#</sup>
<italic toggle="yes">p</italic>&#x02009;&#x0003c;&#x02009;0.05, <sup>##</sup>
<italic toggle="yes">p</italic>&#x02009;&#x0003c;&#x02009;0.01, <sup>###</sup>
<italic toggle="yes">p</italic>&#x02009;&#x0003c;&#x02009;0.001, versus TAC group.</p></caption><graphic xlink:href="JCMM-29-e70617-g001" position="anchor" id="jats-graphic-7"/></fig></sec><sec id="jcmm70617-sec-0019"><label>3.5</label><title>The Protective Effect of <styled-content style="fixed-case" toggle="no">MAT</styled-content> on Atrial Structure Was Diminished by the Activation of the &#x003b2;&#x02010;Catenin Signalling</title><p>To further investigate whether the inhibition of the Wnt3a/&#x003b2;&#x02010;catenin signalling pathway contributes to the protective effect of MAT on TAC mice, we utilised SKL2001 to inhibit the phosphorylation of &#x003b2;&#x02010;catenin, thereby stabilising and activating its expression [<xref rid="jcmm70617-bib-0029" ref-type="bibr">29</xref>]. Firstly, we assessed left ventricular function and atrial structure in mice. The results revealed that compared to the TAC&#x02009;+&#x02009;MAT group, cardiac function was significantly impaired and atrial enlargement occurred in the TAC&#x02009;+&#x02009;MAT + SKL2001 group, indicating an abrogation of MAT's protective effect on cardiac function in TAC mice (Figure&#x000a0;<xref rid="jcmm70617-fig-0005" ref-type="fig">5B&#x02013;H</xref>). Additionally, atrial fibrosis levels and the expression of fibrosis&#x02010;related markers (COL1A1, COL3A1 and &#x003b1;&#x02010;SMA) were assessed using Masson's trichromatic staining and western blotting. The results demonstrated that compared to the TAC&#x02009;+&#x02009;MAT group, the TAC&#x02009;+&#x02009;MAT + SKL2001 group exhibited increased atrial fibrosis levels (Figure&#x000a0;<xref rid="jcmm70617-fig-0005" ref-type="fig">5I,J</xref>), as well as elevated expression levels of COL1A1, COL3A1 and &#x003b1;&#x02010;SMA proteins (Figure&#x000a0;<xref rid="jcmm70617-fig-0005" ref-type="fig">5K&#x02013;N</xref>). These results suggest that MAT's protective effects on atrial remodelling and cardiac function are associated with inhibition of the Wnt3a/&#x003b2;&#x02010;catenin signalling.</p><fig position="float" fig-type="FIGURE" id="jcmm70617-fig-0005"><label>FIGURE 5</label><caption><p>Reversal of the beneficial effect of MAT on atrial remodelling in TAC mice by activation of &#x003b2;&#x02010;catenin. (A) Grouping of experimental animals and schematic diagram of the experiment. (B) Representative echocardiographic images of the atria and ventricle. (C&#x02013;H) Echocardiographic parameters including left ventricular ejection fraction (LVEF), left ventricular shortening fraction (LVFS), left ventricular end&#x02010;diastolic diameter (LVIDd), left ventricular posterior wall diameter (LVPWd), left atrial diameter (LAD) and left atrial diastolic area (<italic toggle="yes">n</italic>&#x02009;=&#x02009;5). (I) Overall cardiac morphology and representative Masson's trichromatic staining images (upper bar&#x02009;=&#x02009;2&#x02009;mm, lower bar&#x02009;=&#x02009;100&#x02009;&#x003bc;m). (J) Percentage of the total area with fibrosis (<italic toggle="yes">n</italic>&#x02009;=&#x02009;5). (K&#x02013;N) Representative western blot images and relative expression of COL1A1, COL3A1 and &#x003b1;&#x02010;SMA in each group of atria (<italic toggle="yes">n</italic>&#x02009;=&#x02009;4). Data were expressed as mean&#x02009;&#x000b1;&#x02009;SEM. **<italic toggle="yes">p</italic>&#x02009;&#x0003c;&#x02009;0.01, ***<italic toggle="yes">p</italic>&#x02009;&#x0003c;&#x02009;0.001, versus TAC&#x02009;+&#x02009;MAT group; <sup>ns</sup>
<italic toggle="yes">p</italic>&#x02009;&#x0003e;&#x02009;0.05, <sup>###</sup>
<italic toggle="yes">p</italic>&#x02009;&#x0003c;&#x02009;0.001, versus TAC group. ns, not significant.</p></caption><graphic xlink:href="JCMM-29-e70617-g007" position="anchor" id="jats-graphic-9"/></fig></sec><sec id="jcmm70617-sec-0020"><label>3.6</label><title>Activation of the &#x003b2;&#x02010;Catenin Signalling Attenuated the Protective Effect of <styled-content style="fixed-case" toggle="no">MAT</styled-content> on Atrial Electrical Signal Conduction</title><p>Next, we investigated the susceptibility of five groups of mice to atrial fibrillation (AF). The results demonstrated that SKL2001 intervention abolished the inhibitory effect of MAT on AF susceptibility, leading to a significant increase in AF susceptibility and a prolonged AF duration in the TAC&#x02009;+&#x02009;MAT&#x02009;+&#x02009;SKL2001 group compared with the TAC&#x02009;+&#x02009;MAT group (Figure&#x000a0;<xref rid="jcmm70617-fig-0006" ref-type="fig">6A&#x02013;C</xref>). Simultaneously, we utilised the Langendorff perfusion system to examine atrial electrical signal conduction, and our findings indicated that MAT can inhibit TAC&#x02010;induced atrial electrical remodelling. Nevertheless, these advantageous effects of MAT were negated following the administration of SKL2001(Figure&#x000a0;<xref rid="jcmm70617-fig-0006" ref-type="fig">6D&#x02013;G</xref>). Furthermore, western blot analysis demonstrated a decrease in connexin expression in mice atrial tissue from the TAC&#x02009;+&#x02009;MAT&#x02009;+&#x02009;SKL2001 group compared with the TAC&#x02009;+&#x02009;MAT group, indicating that SKL2001 eliminated MAT's protective effect on gap junction channels (Figure&#x000a0;<xref rid="jcmm70617-fig-0006" ref-type="fig">6H&#x02013;J</xref>). These findings suggest a correlation between Wnt3a/&#x003b2;&#x02010;catenin signalling and the inhibitory effect of MAT on atrial remodelling.</p><fig position="float" fig-type="FIGURE" id="jcmm70617-fig-0006"><label>FIGURE 6</label><caption><p>Reversal of the beneficial impact of MAT on atrial electrical remodelling in TAC mice by activation of &#x003b2;&#x02010;catenin. (A) Representative ECG traces following burst pacing in the right atrium. The dashed line represents the atrial fibrillation rhythm. (B, C) Summary of AF induction and AF duration in each group (<italic toggle="yes">n</italic>&#x02009;=&#x02009;8). (D) Langendorff electrophysiological mapping images. The bars represent the duration from the initial to the final measurement within one heartbeat (<italic toggle="yes">n</italic>&#x02009;=&#x02009;5). (E&#x02013;G) Summary of left atrial activation patterns. EMapScope 5.0 software was used to calculate the mean conduction velocity, absolute inhomogeneity and inhomogeneity index of the left atrium (<italic toggle="yes">n</italic>&#x02009;=&#x02009;5). (H&#x02013;J) Representative western blot images and relative atrial expression of Cx40 and Cx43 (<italic toggle="yes">n</italic>&#x02009;=&#x02009;4). Data were expressed as mean&#x02009;&#x000b1;&#x02009;SEM. **<italic toggle="yes">p</italic>&#x02009;&#x0003c;&#x02009;0.01, ***<italic toggle="yes">p</italic>&#x02009;&#x0003c;&#x02009;0.001, versus TAC&#x02009;+&#x02009;MAT group; <sup>ns</sup>
<italic toggle="yes">p</italic>&#x02009;&#x0003e;&#x02009;0.05, <sup>###</sup>
<italic toggle="yes">p</italic>&#x02009;&#x0003c;&#x02009;0.001, versus TAC group. ns, not significant.</p></caption><graphic xlink:href="JCMM-29-e70617-g003" position="anchor" id="jats-graphic-11"/></fig></sec><sec id="jcmm70617-sec-0021"><label>3.7</label><title>Activation of the &#x003b2;&#x02010;Catenin Signalling Attenuated the Ameliorative Effects of <styled-content style="fixed-case" toggle="no">MAT</styled-content> on Atrial Inflammation and Fibrosis</title><p>Following treatment with SKL2001, we assessed the expression levels of key molecules involved in the Wnt3a/&#x003b2;&#x02010;catenin signalling pathway. Our results revealed a significant increase in active &#x003b2;&#x02010;catenin and total &#x003b2;&#x02010;catenin expression in the TAC&#x02009;+&#x02009;SKL2001&#x02009;+&#x02009;MAT group compared to the TAC&#x02009;+&#x02009;MAT group. However, there were no notable differences observed in the expression levels of Wnt3a, p&#x02010;GSK3&#x003b2; and GSK3&#x003b2; between these two groups (Figure&#x000a0;<xref rid="jcmm70617-fig-0007" ref-type="fig">7A&#x02013;I</xref>). Immunofluorescence analysis also confirmed these findings for Wnt3a and active &#x003b2;&#x02010;catenin (Figure&#x000a0;<xref rid="jcmm70617-fig-0007" ref-type="fig">7F&#x02013;H</xref>). The nuclear and cytoplasmic levels of active &#x003b2;&#x02010;catenin were found to be significantly elevated in the TAC + SKL2001&#x02009;+&#x02009;MAT group compared to the TAC&#x02009;+&#x02009;MAT group (Figure&#x000a0;<xref rid="jcmm70617-fig-0007" ref-type="fig">7I&#x02013;K</xref>). Furthermore, using western blot analysis, we detected significantly elevated levels of TGF&#x02010;&#x003b2;, MMP2, MMP9, TNF&#x02010;&#x003b1;, IL&#x02010;1&#x003b2; and IL&#x02010;6 proteins in the TAC&#x02009;+&#x02009;MAT + SKL2001 group compared to the TAC&#x02009;+&#x02009;MAT group (Figure&#x000a0;<xref rid="jcmm70617-fig-0007" ref-type="fig">7L&#x02013;R</xref>). As illustrated in Figure&#x000a0;<xref rid="jcmm70617-fig-0007" ref-type="fig">7S</xref>, we elucidated the mechanism by which MAT prevents and treats AF through the Wnt3a/&#x003b2;&#x02010;catenin signalling pathway. In summary, our experiments demonstrated that the combination of MAT and SKL2001 counteracted the inhibitory effect of MAT on the Wnt3a/&#x003b2;&#x02010;catenin signalling pathway, resulting in atrial fibrosis and inflammation.</p><fig position="float" fig-type="FIGURE" id="jcmm70617-fig-0007"><label>FIGURE 7</label><caption><p>The impact of SKL2001 on the Wnt3a/&#x003b2;&#x02010;catenin signalling pathway, atrial fibrosis and inflammation and the mechanisms by which MAT prevents and treats AF. (A&#x02013;E) Representative western blot images and relative atrial expression of Wnt3a, p&#x02010;GSK3&#x003b2;, active &#x003b2;&#x02010;catenin and &#x003b2;&#x02010;catenin in each group of atria. (F&#x02013;H) &#x003b1;&#x02010;actinin/Vimentin (green), Wnt3a/active &#x003b2;&#x02010;catenin (red) and DAPI (blue) immunofluorescence stain representation and Wnt3a/active &#x003b2;&#x02010;catenin relative immunofluorescence intensity (<italic toggle="yes">n</italic>&#x02009;=&#x02009;4). (I&#x02013;K) Representative western blot images and quantification of active &#x003b2;&#x02010;catenin expression in the atrial nucleus or cytoplasm (<italic toggle="yes">n</italic>&#x02009;=&#x02009;4). (L&#x02013;R) Representative western blot images and relative atrial expression of TNF&#x02010;&#x003b1;, IL&#x02010;1&#x003b2;, IL&#x02010;6, TGF&#x02010;&#x003b2;, MMP2 and MM9. (S) Schematic diagram illustrating the mechanism by which MAT inhibits AF via the Wnt3a/&#x003b2;&#x02010;catenin signalling pathway. Data were expressed as mean&#x02009;&#x000b1;&#x02009;SEM. <italic toggle="yes">n</italic>&#x02009;=&#x02009;4 per group. <sup>ns</sup>
<italic toggle="yes">p</italic>&#x02009;&#x0003e;&#x02009;0.05, ***<italic toggle="yes">p</italic>&#x02009;&#x0003c;&#x02009;0.001, versus TAC&#x02009;+&#x02009;MAT group; <sup>ns</sup>
<italic toggle="yes">p</italic>&#x02009;&#x0003e;&#x02009;0.05, <sup>###</sup>
<italic toggle="yes">p</italic>&#x02009;&#x0003c;&#x02009;0.001, versus TAC group. ns, not significant.</p></caption><graphic xlink:href="JCMM-29-e70617-g004" position="anchor" id="jats-graphic-13"/></fig></sec></sec><sec sec-type="discussion" id="jcmm70617-sec-0022"><label>4</label><title>Discussion</title><p>In this study, we showed that TAC surgery induces atrial electrical and structural remodelling, leading to a significant increase in susceptibility to AF. Furthermore, bioinformatics analysis unveiled the activation of diverse signalling pathways in the atrial tissue of TAC mice, notably including the canonical Wnt signalling pathway. Subsequent analysis of human heart tissue samples revealed the activation of the Wnt3a/&#x003b2;&#x02010;catenin signalling pathway in AF patients, which contributes to fibrotic changes such as collagen deposition within the atrial tissue. Moreover, by integrating network pharmacology and experimental investigations, we have uncovered that a natural compound, MAT, possesses the capability to inhibit the Wnt3a/&#x003b2;&#x02010;catenin signalling pathway, thereby attenuating atrial fibrosis and inflammatory responses, ultimately reducing the incidence of TAC&#x02010;induced AF (Figure&#x000a0;<xref rid="jcmm70617-fig-0007" ref-type="fig">7S</xref>). These findings suggest that MAT demonstrates anti&#x02010;arrhythmic effects in pressure overload conditions and underscore the Wnt3a/&#x003b2;&#x02010;catenin signalling pathway as a promising target for managing AF associated with pressure overload.</p><p>The occurrence of AF is frequently accompanied by a myriad of cardiovascular and cerebrovascular complications, including stroke and HF, thereby posing a significant threat to the lives of affected patients [<xref rid="jcmm70617-bib-0023" ref-type="bibr">23</xref>, <xref rid="jcmm70617-bib-0030" ref-type="bibr">30</xref>]. Therefore, there is an increasing emphasis on elucidating the molecular mechanisms underlying AF. Previously, chronic inflammation and atrial fibrosis have been established as key pathogenic factors in AF [<xref rid="jcmm70617-bib-0001" ref-type="bibr">1</xref>]. Concurrently, several studies have demonstrated that cardiac pressure overload markedly exacerbates atrial remodelling and fibrosis, thereby fostering an environment conducive to the development of AF [<xref rid="jcmm70617-bib-0031" ref-type="bibr">31</xref>, <xref rid="jcmm70617-bib-0032" ref-type="bibr">32</xref>]. The involvement of the Wnt signalling pathway in cardiac fibrosis has been observed in studies on arrhythmia [<xref rid="jcmm70617-bib-0033" ref-type="bibr">33</xref>]. The Wnt signalling pathway can be categorised into the canonical and non&#x02010;canonical pathways. In the canonical pathway, binding of Wnt protein to its membrane receptor triggers activation of Dishevelled (Dvl), leading to dissociation of a complex comprising casein kinase 1&#x003b1; (CK1&#x003b1;), GSK&#x02010;3&#x003b2;, adenomatous colon polyp (APC) scaffold protein and Axin. This process avoids &#x003b2;&#x02010;catenin degradation in the cytoplasm, facilitating its nuclear translocation and subsequent binding to T&#x02010;cell factor/lymphoid enhancer&#x02010;binding factor (TCF/LEF) family transcription factors, thereby initiating downstream target gene transcription and inducing subsequent cellular responses [<xref rid="jcmm70617-bib-0034" ref-type="bibr">34</xref>]. Wnt3a is a principal signalling protein within the Wnt family and the Wnt3a/&#x003b2;&#x02010;catenin signalling pathway has been implicated in arrhythmia diseases. Studies by Cai et&#x000a0;al. demonstrated that pathway activation in iPSC&#x02010;CM cell models of Brugada syndrome led to reduced Nav1.5 expression, significantly increasing arrhythmia incidence [<xref rid="jcmm70617-bib-0035" ref-type="bibr">35</xref>]. Additionally, Lv et&#x000a0;al. observed activation of the Wnt3a/&#x003b2;&#x02010;catenin signalling pathway in Ach&#x02010;CaCl<sub>2</sub> induced AF rats, leading to alterations in collagen levels and gap connexin proteins within atrial tissue, thereby promoting atrial fibrosis and facilitating AF occurrence [<xref rid="jcmm70617-bib-0036" ref-type="bibr">36</xref>]. Furthermore, previous studies have demonstrated the modulation of TNF&#x02010;&#x003b1; levels by Wnt signalling, which forms a positive feedback loop between the two pathways [<xref rid="jcmm70617-bib-0037" ref-type="bibr">37</xref>]. In line with previous studies, we have also observed a close association between the Wnt3a/&#x003b2;&#x02010;catenin signalling pathway and AF, resulting in alterations in atrial fibrosis and inflammatory response. What distinguishes our study is the novel evidence linking AF to the Wnt3a/&#x003b2;&#x02010;catenin signalling pathway under pressure overload conditions, offering promise as a potential target for preventing and treating pressure overload&#x02010;induced AF.</p><p>The process of tissue fibrosis mediated by the Wnt3a/&#x003b2;&#x02010;catenin signalling pathway is intricately associated with fibroblasts. Previous studies have demonstrated that overexpression of Wnt3a in fibrocytes leads to a significant upregulation of downstream proteins, including &#x003b2;&#x02010;catenin and cyclinD1, resulting in enhanced proliferation of fibroblasts and fibrotic changes. These findings suggest a potential role for this pathway in the development of epidural fibrosis [<xref rid="jcmm70617-bib-0038" ref-type="bibr">38</xref>]. The presence of similar cascades has been demonstrated in fibroblasts across various studies, including those conducted on kidney and lung tissues [<xref rid="jcmm70617-bib-0039" ref-type="bibr">39</xref>, <xref rid="jcmm70617-bib-0040" ref-type="bibr">40</xref>]. Notably, it has been observed that pressure overload in the right heart resulted in upregulation of the Wnt/ &#x003b2;&#x02010;catenin signalling pathway. Stimulation of cardiac fibroblasts with Wnt3a significantly enhanced &#x003b2;&#x02010;catenin activation within these cells, facilitating its translocation into the nucleus and subsequently mediating FOS&#x02010;proto&#x02010;oncogene&#x02010;like 1/2 (FOSL1/2) transcriptionally. This cascade ultimately leads to proliferation and aggregation of cardiac fibroblasts, contributing to cardiac remodelling [<xref rid="jcmm70617-bib-0009" ref-type="bibr">9</xref>]. In addition, in our study, we found that the inflammatory response is downstream of the Wnt3a/&#x003b2;&#x02010;catenin pathway and plays an independent role. Other studies have also reported that &#x003b2;&#x02010;catenin can enhance its transcriptional activity by directly binding to the NF&#x02010;&#x003ba;B promoter region, thereby promoting the release of pro&#x02010;inflammatory factors such as TNF&#x02010;&#x003b1; and IL&#x02010;1 [<xref rid="jcmm70617-bib-0010" ref-type="bibr">10</xref>]. Notably, the contribution of inflammation to AF extends beyond structural remodelling. It was also observed that MAT treatment significantly restored the expression of Cx40 and Cx43, suggesting that inflammation may damage gap junction proteins through oxidative stress [<xref rid="jcmm70617-bib-0041" ref-type="bibr">41</xref>], thereby disrupting electrical conduction synchronisation. Clinical studies further revealed that the IL&#x02010;1&#x003b2; level in the atrial tissue of patients with AF is positively correlated with the degree of electrical remodelling [<xref rid="jcmm70617-bib-0042" ref-type="bibr">42</xref>]. Therefore, targeting the Wnt3a/&#x003b2;&#x02010;catenin signalling pathway and exploring innovative approaches to modulate this pathway may provide effective strategies for managing AF induced by pressure overload.</p><p>The beneficial effects of MAT on the cardiovascular system have been extensively documented in various cardiovascular diseases, including HF, diabetic cardiomyopathy and myocardial ischemia&#x02013;reperfusion injury [<xref rid="jcmm70617-bib-0043" ref-type="bibr">43</xref>, <xref rid="jcmm70617-bib-0044" ref-type="bibr">44</xref>, <xref rid="jcmm70617-bib-0045" ref-type="bibr">45</xref>]. In the context of arrhythmia&#x02010;related disorders, MAT can also mitigate the incidence of arrhythmias by modulating ion channels and inhibiting cardiac fibrosis [<xref rid="jcmm70617-bib-0015" ref-type="bibr">15</xref>, <xref rid="jcmm70617-bib-0020" ref-type="bibr">20</xref>]. In this study, we observed that MAT effectively mitigated atrial Wnt3a/&#x003b2;&#x02010;catenin signalling and fibrosis markers under conditions of pressure overload. Furthermore, MAT demonstrated the ability to ameliorate atrial electrical and structural remodelling induced by TAC, thereby reducing susceptibility to AF. To our knowledge, this study is the first to unveil the advantageous effects of MAT on pressure overload&#x02010;related AF, despite previous reports highlighting its anti&#x02010;arrhythmic properties in rat models of myocardial infarction (MI) [<xref rid="jcmm70617-bib-0020" ref-type="bibr">20</xref>]. Notably, Shi et&#x000a0;al. demonstrated that MAT effectively reverses liver epithelial&#x02010;mesenchymal transformation (EMT) by inhibiting the Wnt&#x02010;1/&#x003b2;&#x02010;catenin signalling pathway, thereby suppressing liver fibrosis progression [<xref rid="jcmm70617-bib-0046" ref-type="bibr">46</xref>]. Moreover, in the investigation of acute myeloid leukaemia (AML), MAT exhibited enhanced induction of apoptosis and cell cycle arrest through inhibition of the Wnt/&#x003b2;&#x02010;catenin signalling pathway, thereby exerting a favourable impact on impeding AML progression [<xref rid="jcmm70617-bib-0047" ref-type="bibr">47</xref>]. Here, we employed a pharmacological intervention to achieve stable expression of &#x003b2;&#x02010;catenin in&#x000a0;vivo. Remarkably, our findings revealed that the cardioprotective effects of MAT were abrogated upon stable expression of &#x003b2;&#x02010;catenin, thereby further substantiating the involvement of the Wnt3a/&#x003b2;&#x02010;catenin signalling pathway in mediating MAT's actions.</p><p>The study has several limitations. First, our investigation focused on the regulatory effects of Wnt3a on downstream molecules in fibroblasts; however, the potential roles of Wnt3a in other atrial cell types remain largely unexplored. Second, previous studies have demonstrated that Wnt3a is not only closely associated with cardiac fibrosis but also that its upregulation is linked to myocardial hypertrophy [<xref rid="jcmm70617-bib-0048" ref-type="bibr">48</xref>]. Given the therapeutic efficacy of MAT on ventricular hypertrophy [<xref rid="jcmm70617-bib-0049" ref-type="bibr">49</xref>], further exploration of its underlying mechanisms is warranted. Finally, other members of the Wnt family have been shown to significantly influence AF pathogenesis. For instance, Feng et&#x000a0;al. reported that Ach&#x02010;CaCl<sub>2</sub> stimulation induces upregulation of atrial Wnt5a expression, elevates TGF&#x02010;&#x003b2; levels and exacerbates atrial tissue fibrosis, thereby markedly increasing the incidence of AF [<xref rid="jcmm70617-bib-0050" ref-type="bibr">50</xref>]. These findings strongly suggest that other Wnt family members may also contribute to pressure overload&#x02010;induced AF, necessitating further investigation into the therapeutic effects of MAT on these pathways.</p></sec><sec sec-type="conclusions" id="jcmm70617-sec-0023"><label>5</label><title>Conclusion</title><p>In conclusion, this study reveals that pressure overload triggers activation of the atrial Wnt3a/&#x003b2;&#x02010;catenin signalling pathway, resulting in increased susceptibility to AF by fostering atrial fibrosis and inflammatory responses and exacerbating atrial structural and electrical remodelling. Treatment with MAT shows promise in alleviating atrial structural and electrical remodelling by inhibiting the Wnt3a/&#x003b2;&#x02010;catenin signalling pathway, consequently lowering the risk of AF development. In summary, our findings underscore the potential of MAT therapy as an intervention to prevent arrhythmias induced by heart failure, offering a promising avenue for managing these cardiac conditions.</p></sec><sec id="jcmm70617-sec-0028"><title>Author Contributions</title><p>
<bold>Guoxin Zhang:</bold> data curation (equal), formal analysis (equal), writing &#x02013; original draft (equal), writing &#x02013; review and editing (equal). <bold>Xue Dong:</bold> visualization (equal), writing &#x02013; review and editing (equal). <bold>Boxuan Sun:</bold> investigation (equal), methodology (equal). <bold>Zijun Zhou:</bold> investigation (equal), methodology (equal). <bold>Yinli Xu:</bold> investigation (equal), methodology (equal). <bold>Yuting Huang:</bold> investigation (equal), methodology (equal). <bold>Shan Meng:</bold> investigation (equal), methodology (equal). <bold>Zijun Cao:</bold> investigation (equal), methodology (equal). <bold>Nana Qin:</bold> investigation (equal), methodology (equal). <bold>Yan Zhu:</bold> methodology (equal), resources (equal). <bold>Liming Yu:</bold> conceptualization (equal), funding acquisition (equal), project administration (equal), supervision (equal), writing &#x02013; review and editing (equal). <bold>Huishan Wang:</bold> conceptualization (equal), funding acquisition (equal), project administration (equal), supervision (equal), writing &#x02013; review and editing (equal).</p></sec><sec sec-type="COI-statement" id="jcmm70617-sec-0025"><title>Conflicts of Interest</title><p>The authors declare no conflicts of interest.</p></sec><sec sec-type="supplementary-material"><title>Supporting information</title><supplementary-material id="jcmm70617-supitem-0001" position="float" content-type="local-data"><caption><p>
<bold>Figure S1.</bold> Preliminary analysis of mice in the Sham and Sham+MAT groups. (A) Representative.</p></caption><media xlink:href="JCMM-29-e70617-s003.pdf"/></supplementary-material><supplementary-material id="jcmm70617-supitem-0002" position="float" content-type="local-data"><caption><p>
<bold>Table&#x000a0;S1.</bold> Patient demographics.</p></caption><media xlink:href="JCMM-29-e70617-s002.docx"/></supplementary-material><supplementary-material id="jcmm70617-supitem-0003" position="float" content-type="local-data"><caption><p>
<bold>Table&#x000a0;S2.</bold> Antibodies information.</p></caption><media xlink:href="JCMM-29-e70617-s004.docx"/></supplementary-material><supplementary-material id="jcmm70617-supitem-0004" position="float" content-type="local-data"><caption><p>
<bold>Table&#x000a0;S3.</bold> The baseline characteristics of the mice.</p></caption><media xlink:href="JCMM-29-e70617-s001.docx"/></supplementary-material></sec></body><back><ack id="jcmm70617-sec-0024"><title>Acknowledgements</title><p>The authors have nothing to report.</p></ack><sec sec-type="data-availability" id="jcmm70617-sec-0027"><title>Data Availability Statement</title><p>The data supporting the findings of this study are available from the corresponding author upon reasonable request.</p></sec><ref-list content-type="cited-references" id="jcmm70617-bibl-0001"><title>References</title><ref id="jcmm70617-bib-0001"><label>1</label><mixed-citation publication-type="journal" id="jcmm70617-cit-0001">
<string-name>
<given-names>B.</given-names>
<surname>Brundel</surname>
</string-name>, <string-name>
<given-names>X.</given-names>
<surname>Ai</surname>
</string-name>, <string-name>
<given-names>M. T.</given-names>
<surname>Hills</surname>
</string-name>, <string-name>
<given-names>M. F.</given-names>
<surname>Kuipers</surname>
</string-name>, <string-name>
<given-names>G. Y. H.</given-names>
<surname>Lip</surname>
</string-name>, and <string-name>
<given-names>N. M. S.</given-names>
<surname>de Groot</surname>
</string-name>, &#x0201c;<article-title>Atrial Fibrillation</article-title>,&#x0201d; <source>Nature Reviews. Disease Primers</source>
<volume>8</volume>, no. <issue>1</issue> (<year>2022</year>): <fpage>21</fpage>.</mixed-citation></ref><ref id="jcmm70617-bib-0002"><label>2</label><mixed-citation publication-type="journal" id="jcmm70617-cit-0002">
<string-name>
<given-names>G.</given-names>
<surname>Hindricks</surname>
</string-name>, <string-name>
<given-names>T.</given-names>
<surname>Potpara</surname>
</string-name>, <string-name>
<given-names>N.</given-names>
<surname>Dagres</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>2020 ESC Guidelines for the Diagnosis and Management of Atrial Fibrillation Developed in Collaboration With the European Association for Cardio&#x02010;Thoracic Surgery (EACTS): The Task Force for the Diagnosis and Management of Atrial Fibrillation of the European Society of Cardiology (ESC) Developed With the Special Contribution of the European Heart Rhythm Association (EHRA) of the ESC</article-title>,&#x0201d; <source>European Heart Journal</source>
<volume>42</volume>, no. <issue>5</issue> (<year>2021</year>): <fpage>373</fpage>&#x02013;<lpage>498</lpage>.<pub-id pub-id-type="pmid">32860505</pub-id>
</mixed-citation></ref><ref id="jcmm70617-bib-0003"><label>3</label><mixed-citation publication-type="journal" id="jcmm70617-cit-0003">
<string-name>
<given-names>A.</given-names>
<surname>Goette</surname>
</string-name> and <string-name>
<given-names>U.</given-names>
<surname>Lendeckel</surname>
</string-name>, &#x0201c;<article-title>Atrial Cardiomyopathy: Pathophysiology and Clinical Consequences</article-title>,&#x0201d; <source>Cells</source>
<volume>10</volume>, no. <issue>10</issue> (<year>2021</year>): <elocation-id>2605</elocation-id>.<pub-id pub-id-type="pmid">34685585</pub-id>
</mixed-citation></ref><ref id="jcmm70617-bib-0004"><label>4</label><mixed-citation publication-type="journal" id="jcmm70617-cit-0004">
<string-name>
<given-names>K.</given-names>
<surname>Yoshida</surname>
</string-name>, <string-name>
<given-names>M.</given-names>
<surname>Ulfarsson</surname>
</string-name>, <string-name>
<given-names>H.</given-names>
<surname>Oral</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>Left Atrial Pressure and Dominant Frequency of Atrial Fibrillation in Humans</article-title>,&#x0201d; <source>Heart Rhythm</source>
<volume>8</volume>, no. <issue>2</issue> (<year>2011</year>): <fpage>181</fpage>&#x02013;<lpage>187</lpage>.<pub-id pub-id-type="pmid">21034858</pub-id>
</mixed-citation></ref><ref id="jcmm70617-bib-0005"><label>5</label><mixed-citation publication-type="journal" id="jcmm70617-cit-0005">
<string-name>
<given-names>Q.</given-names>
<surname>Zhang</surname>
</string-name>, <string-name>
<given-names>L.</given-names>
<surname>Wang</surname>
</string-name>, <string-name>
<given-names>S.</given-names>
<surname>Wang</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>Signaling Pathways and Targeted Therapy for Myocardial Infarction</article-title>,&#x0201d; <source>Signal Transduction and Targeted Therapy</source>
<volume>7</volume>, no. <issue>1</issue> (<year>2022</year>): <fpage>78</fpage>.<pub-id pub-id-type="pmid">35273164</pub-id>
</mixed-citation></ref><ref id="jcmm70617-bib-0006"><label>6</label><mixed-citation publication-type="journal" id="jcmm70617-cit-0006">
<string-name>
<given-names>C.</given-names>
<surname>Wolke</surname>
</string-name>, <string-name>
<given-names>E.</given-names>
<surname>Antileo</surname>
</string-name>, and <string-name>
<given-names>U.</given-names>
<surname>Lendeckel</surname>
</string-name>, &#x0201c;<article-title>WNT Signaling in Atrial Fibrillation</article-title>,&#x0201d; <source>Experimental Biology and Medicine</source>
<volume>246</volume>, no. <issue>9</issue> (<year>2021</year>): <fpage>1112</fpage>&#x02013;<lpage>1120</lpage>.<pub-id pub-id-type="pmid">33641440</pub-id>
</mixed-citation></ref><ref id="jcmm70617-bib-0007"><label>7</label><mixed-citation publication-type="journal" id="jcmm70617-cit-0007">
<string-name>
<given-names>E.</given-names>
<surname>Dzia&#x00142;o</surname>
</string-name>, <string-name>
<given-names>M.</given-names>
<surname>Rudnik</surname>
</string-name>, <string-name>
<given-names>R. I.</given-names>
<surname>Koning</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>WNT3a and WNT5a Transported by Exosomes Activate WNT Signaling Pathways in Human Cardiac Fibroblasts</article-title>,&#x0201d; <source>International Journal of Molecular Sciences</source>
<volume>20</volume>, no. <issue>6</issue> (<year>2019</year>): <elocation-id>1436</elocation-id>.<pub-id pub-id-type="pmid">30901906</pub-id>
</mixed-citation></ref><ref id="jcmm70617-bib-0008"><label>8</label><mixed-citation publication-type="journal" id="jcmm70617-cit-0008">
<string-name>
<given-names>T.</given-names>
<surname>Kadota</surname>
</string-name>, <string-name>
<given-names>Y.</given-names>
<surname>Fujita</surname>
</string-name>, <string-name>
<given-names>J.</given-names>
<surname>Araya</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>Human Bronchial Epithelial Cell&#x02010;Derived Extracellular Vesicle Therapy for Pulmonary Fibrosis via Inhibition of TGF&#x02010;&#x003b2;&#x02010;WNT Crosstalk</article-title>,&#x0201d; <source>Journal of Extracellular Vesicles</source>
<volume>10</volume>, no. <issue>10</issue> (<year>2021</year>): <elocation-id>e12124</elocation-id>.<pub-id pub-id-type="pmid">34377373</pub-id>
</mixed-citation></ref><ref id="jcmm70617-bib-0009"><label>9</label><mixed-citation publication-type="journal" id="jcmm70617-cit-0009">
<string-name>
<given-names>S. R.</given-names>
<surname>Nayakanti</surname>
</string-name>, <string-name>
<given-names>A.</given-names>
<surname>Friedrich</surname>
</string-name>, <string-name>
<given-names>P.</given-names>
<surname>Sarode</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>Targeting Wnt&#x02010;&#x000df;&#x02010;Catenin&#x02010;FOSL Signaling Ameliorates Right Ventricular Remodeling</article-title>,&#x0201d; <source>Circulation Research</source>
<volume>132</volume>, no. <issue>11</issue> (<year>2023</year>): <fpage>1468</fpage>&#x02013;<lpage>1485</lpage>.<pub-id pub-id-type="pmid">37042252</pub-id>
</mixed-citation></ref><ref id="jcmm70617-bib-0010"><label>10</label><mixed-citation publication-type="journal" id="jcmm70617-cit-0010">
<string-name>
<given-names>X.</given-names>
<surname>Guan</surname>
</string-name>, <string-name>
<given-names>Y.</given-names>
<surname>He</surname>
</string-name>, <string-name>
<given-names>Z.</given-names>
<surname>Wei</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>Crosstalk Between Wnt/&#x003b2;&#x02010;Catenin Signaling and NF&#x02010;&#x003ba;B Signaling Contributes to Apical Periodontitis</article-title>,&#x0201d; <source>International Immunopharmacology</source>
<volume>98</volume> (<year>2021</year>): <elocation-id>107843</elocation-id>.<pub-id pub-id-type="pmid">34153668</pub-id>
</mixed-citation></ref><ref id="jcmm70617-bib-0011"><label>11</label><mixed-citation publication-type="journal" id="jcmm70617-cit-0011">
<string-name>
<given-names>W.</given-names>
<surname>Yang</surname>
</string-name>, <string-name>
<given-names>Q.</given-names>
<surname>Zhao</surname>
</string-name>, <string-name>
<given-names>M.</given-names>
<surname>Yao</surname>
</string-name>, <string-name>
<given-names>X.</given-names>
<surname>Li</surname>
</string-name>, <string-name>
<given-names>Z.</given-names>
<surname>Shan</surname>
</string-name>, and <string-name>
<given-names>Y.</given-names>
<surname>Wang</surname>
</string-name>, &#x0201c;<article-title>The Transformation of Atrial Fibroblasts Into Myofibroblasts Is Promoted by Trimethylamine N&#x02010;Oxide via the Wnt3a/&#x003b2;&#x02010;Catenin Signaling Pathway</article-title>,&#x0201d; <source>Journal of Thoracic Disease</source>
<volume>14</volume>, no. <issue>5</issue> (<year>2022</year>): <fpage>1526</fpage>&#x02013;<lpage>1536</lpage>.<pub-id pub-id-type="pmid">35693618</pub-id>
</mixed-citation></ref><ref id="jcmm70617-bib-0012"><label>12</label><mixed-citation publication-type="journal" id="jcmm70617-cit-0012">
<string-name>
<given-names>X.</given-names>
<surname>Li</surname>
</string-name>, <string-name>
<given-names>Z.</given-names>
<surname>Tang</surname>
</string-name>, <string-name>
<given-names>L.</given-names>
<surname>Wen</surname>
</string-name>, <string-name>
<given-names>C.</given-names>
<surname>Jiang</surname>
</string-name>, and <string-name>
<given-names>Q.</given-names>
<surname>Feng</surname>
</string-name>, &#x0201c;<article-title>Matrine: A Review of Its Pharmacology, Pharmacokinetics, Toxicity, Clinical Application and Preparation Researches</article-title>,&#x0201d; <source>Journal of Ethnopharmacology</source>
<volume>269</volume> (<year>2021</year>): <elocation-id>113682</elocation-id>.<pub-id pub-id-type="pmid">33307055</pub-id>
</mixed-citation></ref><ref id="jcmm70617-bib-0013"><label>13</label><mixed-citation publication-type="journal" id="jcmm70617-cit-0013">
<string-name>
<given-names>Y. J.</given-names>
<surname>Zhang</surname>
</string-name>, <string-name>
<given-names>M. X.</given-names>
<surname>Xiang</surname>
</string-name>, <string-name>
<given-names>J.</given-names>
<surname>San</surname>
</string-name>, <string-name>
<given-names>G.</given-names>
<surname>Cheng</surname>
</string-name>, and <string-name>
<given-names>S. S.</given-names>
<surname>Wang</surname>
</string-name>, &#x0201c;<article-title>Effect of Matrine and Carvedilol on Collagen and MMPs Activity of Hypertrophy Myocardium Induced by Pressure Overload</article-title>,&#x0201d; <source>Journal of Zhejiang University. Science. B</source>
<volume>7</volume>, no. <issue>3</issue> (<year>2006</year>): <fpage>245</fpage>&#x02013;<lpage>250</lpage>.<pub-id pub-id-type="pmid">16502514</pub-id>
</mixed-citation></ref><ref id="jcmm70617-bib-0014"><label>14</label><mixed-citation publication-type="journal" id="jcmm70617-cit-0014">
<string-name>
<given-names>X.</given-names>
<surname>Zhang</surname>
</string-name>, <string-name>
<given-names>C.</given-names>
<surname>Hu</surname>
</string-name>, <string-name>
<given-names>N.</given-names>
<surname>Zhang</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>Matrine Attenuates Pathological Cardiac Fibrosis via RPS5/p38 in Mice</article-title>,&#x0201d; <source>Acta Pharmacologica Sinica</source>
<volume>42</volume>, no. <issue>4</issue> (<year>2021</year>): <fpage>573</fpage>&#x02013;<lpage>584</lpage>.<pub-id pub-id-type="pmid">32694761</pub-id>
</mixed-citation></ref><ref id="jcmm70617-bib-0015"><label>15</label><mixed-citation publication-type="journal" id="jcmm70617-cit-0015">
<string-name>
<given-names>Y.</given-names>
<surname>Zhou</surname>
</string-name>, <string-name>
<given-names>W.</given-names>
<surname>Xu</surname>
</string-name>, <string-name>
<given-names>R.</given-names>
<surname>Han</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>Matrine Inhibits Pacing Induced Atrial Fibrillation by Modulating I(KM3) and I(Ca&#x02010;L)</article-title>,&#x0201d; <source>International Journal of Biological Sciences</source>
<volume>8</volume>, no. <issue>1</issue> (<year>2012</year>): <fpage>150</fpage>&#x02013;<lpage>158</lpage>.<pub-id pub-id-type="pmid">22211113</pub-id>
</mixed-citation></ref><ref id="jcmm70617-bib-0016"><label>16</label><mixed-citation publication-type="journal" id="jcmm70617-cit-0016">
<string-name>
<given-names>S.</given-names>
<surname>Meng</surname>
</string-name>, <string-name>
<given-names>X.</given-names>
<surname>Chen</surname>
</string-name>, <string-name>
<given-names>J.</given-names>
<surname>Zhao</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>Reduced FNDC5&#x02010;AMPK Signaling in Diabetic Atrium Increases the Susceptibility of Atrial Fibrillation by Impairing Mitochondrial Dynamics and Activating NLRP3 Inflammasome</article-title>,&#x0201d; <source>Biochemical Pharmacology</source>
<volume>229</volume> (<year>2024</year>): <elocation-id>116476</elocation-id>.<pub-id pub-id-type="pmid">39128588</pub-id>
</mixed-citation></ref><ref id="jcmm70617-bib-0017"><label>17</label><mixed-citation publication-type="journal" id="jcmm70617-cit-0017">
<string-name>
<given-names>X.</given-names>
<surname>Guo</surname>
</string-name>, <string-name>
<given-names>T.</given-names>
<surname>Huang</surname>
</string-name>, <string-name>
<given-names>Y.</given-names>
<surname>Xu</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>Early Inhibition of the ATM/p53 Pathway Reduces the Susceptibility to Atrial Fibrillation and Atrial Remodeling Following Acute Myocardial Infarction</article-title>,&#x0201d; <source>Cellular Signalling</source>
<volume>122</volume> (<year>2024</year>): <elocation-id>111322</elocation-id>.<pub-id pub-id-type="pmid">39067835</pub-id>
</mixed-citation></ref><ref id="jcmm70617-bib-0018"><label>18</label><mixed-citation publication-type="journal" id="jcmm70617-cit-0018">
<string-name>
<given-names>D.</given-names>
<surname>Tang</surname>
</string-name>, <string-name>
<given-names>M.</given-names>
<surname>Chen</surname>
</string-name>, <string-name>
<given-names>X.</given-names>
<surname>Huang</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>SRplot: A Free Online Platform for Data Visualization and Graphing</article-title>,&#x0201d; <source>PLoS One</source>
<volume>18</volume>, no. <issue>11</issue> (<year>2023</year>): <elocation-id>e0294236</elocation-id>.<pub-id pub-id-type="pmid">37943830</pub-id>
</mixed-citation></ref><ref id="jcmm70617-bib-0019"><label>19</label><mixed-citation publication-type="journal" id="jcmm70617-cit-0019">
<string-name>
<given-names>N.</given-names>
<surname>Yamaguchi</surname>
</string-name>, <string-name>
<given-names>J.</given-names>
<surname>Xiao</surname>
</string-name>, <string-name>
<given-names>D.</given-names>
<surname>Narke</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>Cardiac Pressure Overload Decreases ETV1 Expression in the Left Atrium, Contributing to Atrial Electrical and Structural Remodeling</article-title>,&#x0201d; <source>Circulation</source>
<volume>143</volume>, no. <issue>8</issue> (<year>2021</year>): <fpage>805</fpage>&#x02013;<lpage>820</lpage>.<pub-id pub-id-type="pmid">33225722</pub-id>
</mixed-citation></ref><ref id="jcmm70617-bib-0020"><label>20</label><mixed-citation publication-type="journal" id="jcmm70617-cit-0020">
<string-name>
<given-names>J.</given-names>
<surname>Ma</surname>
</string-name>, <string-name>
<given-names>S.</given-names>
<surname>Ma</surname>
</string-name>, <string-name>
<given-names>C.</given-names>
<surname>Yin</surname>
</string-name>, and <string-name>
<given-names>H.</given-names>
<surname>Wu</surname>
</string-name>, &#x0201c;<article-title>Matrine Reduces Susceptibility to Postinfarct Atrial Fibrillation in Rats due to Antifibrotic Properties</article-title>,&#x0201d; <source>Journal of Cardiovascular Electrophysiology</source>
<volume>29</volume>, no. <issue>4</issue> (<year>2018</year>): <fpage>616</fpage>&#x02013;<lpage>627</lpage>.<pub-id pub-id-type="pmid">29377366</pub-id>
</mixed-citation></ref><ref id="jcmm70617-bib-0021"><label>21</label><mixed-citation publication-type="journal" id="jcmm70617-cit-0021">
<string-name>
<given-names>H.</given-names>
<surname>Gong</surname>
</string-name>, <string-name>
<given-names>Q.</given-names>
<surname>Niu</surname>
</string-name>, <string-name>
<given-names>Y.</given-names>
<surname>Zhou</surname>
</string-name>, <string-name>
<given-names>Y. X.</given-names>
<surname>Wang</surname>
</string-name>, <string-name>
<given-names>X. F.</given-names>
<surname>Xu</surname>
</string-name>, and <string-name>
<given-names>K. Z.</given-names>
<surname>Hou</surname>
</string-name>, &#x0201c;<article-title>Notum Palmitoleoyl&#x02010;Protein Carboxylesterase Regulates Fas Cell Surface Death Receptor&#x02010;Mediated Apoptosis via the Wnt Signaling Pathway in Colon Adenocarcinoma</article-title>,&#x0201d; <source>Bioengineered</source>
<volume>12</volume>, no. <issue>1</issue> (<year>2021</year>): <fpage>5241</fpage>&#x02013;<lpage>5252</lpage>.<pub-id pub-id-type="pmid">34402722</pub-id>
</mixed-citation></ref><ref id="jcmm70617-bib-0022"><label>22</label><mixed-citation publication-type="journal" id="jcmm70617-cit-0022">
<string-name>
<given-names>L. M.</given-names>
<surname>Yu</surname>
</string-name>, <string-name>
<given-names>X.</given-names>
<surname>Dong</surname>
</string-name>, <string-name>
<given-names>T.</given-names>
<surname>Huang</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>Inhibition of Ferroptosis by Icariin Treatment Attenuates Excessive Ethanol Consumption&#x02010;Induced Atrial Remodeling and Susceptibility to Atrial Fibrillation, Role of SIRT1</article-title>,&#x0201d; <source>Apoptosis: An International Journal on Programmed Cell Death</source>
<volume>28</volume>, no. <issue>3&#x02013;4</issue> (<year>2023</year>): <fpage>607</fpage>&#x02013;<lpage>626</lpage>.<pub-id pub-id-type="pmid">36708428</pub-id>
</mixed-citation></ref><ref id="jcmm70617-bib-0023"><label>23</label><mixed-citation publication-type="journal" id="jcmm70617-cit-0023">
<string-name>
<given-names>L. M.</given-names>
<surname>Yu</surname>
</string-name>, <string-name>
<given-names>X.</given-names>
<surname>Dong</surname>
</string-name>, <string-name>
<given-names>Y. L.</given-names>
<surname>Xu</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>Icariin Attenuates Excessive Alcohol Consumption&#x02010;Induced Susceptibility to Atrial Fibrillation Through SIRT3 Signaling</article-title>,&#x0201d; <source>Biochimica et Biophysica Acta. Molecular Basis of Disease</source>
<volume>1868</volume>, no. <issue>10</issue> (<year>2022</year>): <elocation-id>166483</elocation-id>.<pub-id pub-id-type="pmid">35798229</pub-id>
</mixed-citation></ref><ref id="jcmm70617-bib-0024"><label>24</label><mixed-citation publication-type="journal" id="jcmm70617-cit-0024">
<string-name>
<given-names>W.</given-names>
<surname>Ren</surname>
</string-name>, <string-name>
<given-names>Y.</given-names>
<surname>Huang</surname>
</string-name>, <string-name>
<given-names>S.</given-names>
<surname>Meng</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>Salidroside Treatment Decreases the Susceptibility of Atrial Fibrillation in Diabetic Mice by Reducing mTOR&#x02010;STAT3&#x02010;MCP&#x02010;1 Signaling and Atrial Inflammation</article-title>,&#x0201d; <source>International Immunopharmacology</source>
<volume>142</volume>, no. <issue>Pt B</issue> (<year>2024</year>): <elocation-id>113196</elocation-id>.<pub-id pub-id-type="pmid">39306893</pub-id>
</mixed-citation></ref><ref id="jcmm70617-bib-0025"><label>25</label><mixed-citation publication-type="journal" id="jcmm70617-cit-0025">
<string-name>
<given-names>R.</given-names>
<surname>Tan</surname>
</string-name>, <string-name>
<given-names>T.</given-names>
<surname>Cong</surname>
</string-name>, <string-name>
<given-names>G.</given-names>
<surname>Xu</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>Anthracycline&#x02010;Induced Atrial Structural and Electrical Remodeling Characterizes Early Cardiotoxicity and Contributes to Atrial Conductive Instability and Dysfunction</article-title>,&#x0201d; <source>Antioxidants &#x00026; Redox Signaling</source>
<volume>37</volume>, no. <issue>1&#x02013;3</issue> (<year>2022</year>): <fpage>19</fpage>&#x02013;<lpage>39</lpage>.<pub-id pub-id-type="pmid">35081742</pub-id>
</mixed-citation></ref><ref id="jcmm70617-bib-0026"><label>26</label><mixed-citation publication-type="journal" id="jcmm70617-cit-0026">
<string-name>
<given-names>R.</given-names>
<surname>Lakin</surname>
</string-name>, <string-name>
<given-names>N.</given-names>
<surname>Polidovitch</surname>
</string-name>, <string-name>
<given-names>S.</given-names>
<surname>Yang</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>Cardiomyocyte and Endothelial Cells Play Distinct Roles in the Tumour Necrosis Factor (TNF)&#x02010;Dependent Atrial Responses and Increased Atrial Fibrillation Vulnerability Induced by Endurance Exercise Training in Mice</article-title>,&#x0201d; <source>Cardiovascular Research</source>
<volume>119</volume>, no. <issue>16</issue> (<year>2023</year>): <fpage>2607</fpage>&#x02013;<lpage>2622</lpage>.<pub-id pub-id-type="pmid">37713664</pub-id>
</mixed-citation></ref><ref id="jcmm70617-bib-0027"><label>27</label><mixed-citation publication-type="journal" id="jcmm70617-cit-0027">
<string-name>
<given-names>Y.</given-names>
<surname>Zhang</surname>
</string-name>, <string-name>
<given-names>L.</given-names>
<surname>Zhang</surname>
</string-name>, <string-name>
<given-names>X.</given-names>
<surname>Fan</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>Captopril Attenuates TAC&#x02010;Induced Heart Failure via Inhibiting Wnt3a/&#x003b2;&#x02010;Catenin and Jak2/Stat3 Pathways</article-title>,&#x0201d; <source>Biomedicine &#x00026; Pharmacotherapy = Biomedecine &#x00026; Pharmacotherapie</source>
<volume>113</volume> (<year>2019</year>): <elocation-id>108780</elocation-id>.<pub-id pub-id-type="pmid">30889487</pub-id>
</mixed-citation></ref><ref id="jcmm70617-bib-0028"><label>28</label><mixed-citation publication-type="journal" id="jcmm70617-cit-0028">
<string-name>
<given-names>M.</given-names>
<surname>Yang</surname>
</string-name>, <string-name>
<given-names>H.</given-names>
<surname>Wu</surname>
</string-name>, <string-name>
<given-names>H.</given-names>
<surname>Qian</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>Linggui Zhugan Decoction Delays Ventricular Remodeling in Rats With Chronic Heart Failure After Myocardial Infarction Through the Wnt/&#x003b2;&#x02010;Catenin Signaling Pathway</article-title>,&#x0201d; <source>Phytomedicine: International Journal of Phytotherapy and Phytopharmacology</source>
<volume>120</volume> (<year>2023</year>): <elocation-id>155026</elocation-id>.<pub-id pub-id-type="pmid">37619320</pub-id>
</mixed-citation></ref><ref id="jcmm70617-bib-0029"><label>29</label><mixed-citation publication-type="journal" id="jcmm70617-cit-0029">
<string-name>
<given-names>J.</given-names>
<surname>Gwak</surname>
</string-name>, <string-name>
<given-names>S. G.</given-names>
<surname>Hwang</surname>
</string-name>, <string-name>
<given-names>H. S.</given-names>
<surname>Park</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>Small Molecule&#x02010;Based Disruption of the Axin/&#x003b2;&#x02010;Catenin Protein Complex Regulates Mesenchymal Stem Cell Differentiation</article-title>,&#x0201d; <source>Cell Research</source>
<volume>22</volume>, no. <issue>1</issue> (<year>2012</year>): <fpage>237</fpage>&#x02013;<lpage>247</lpage>.<pub-id pub-id-type="pmid">21826110</pub-id>
</mixed-citation></ref><ref id="jcmm70617-bib-0030"><label>30</label><mixed-citation publication-type="journal" id="jcmm70617-cit-0030">
<string-name>
<given-names>L. M.</given-names>
<surname>Yu</surname>
</string-name>, <string-name>
<given-names>X.</given-names>
<surname>Dong</surname>
</string-name>, <string-name>
<given-names>J. K.</given-names>
<surname>Zhao</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>Activation of PKG&#x02010;CREB&#x02010;KLF15 by Melatonin Attenuates Angiotensin II&#x02010;Induced Vulnerability to Atrial Fibrillation via Enhancing Branched&#x02010;Chain Amino Acids Catabolism</article-title>,&#x0201d; <source>Free Radical Biology &#x00026; Medicine</source>
<volume>178</volume> (<year>2022</year>): <fpage>202</fpage>&#x02013;<lpage>214</lpage>.<pub-id pub-id-type="pmid">34864165</pub-id>
</mixed-citation></ref><ref id="jcmm70617-bib-0031"><label>31</label><mixed-citation publication-type="journal" id="jcmm70617-cit-0031">
<string-name>
<given-names>J. A.</given-names>
<surname>Navarro&#x02010;Garcia</surname>
</string-name>, <string-name>
<given-names>S. K.</given-names>
<surname>Lahiri</surname>
</string-name>, <string-name>
<given-names>Y.</given-names>
<surname>Aguilar&#x02010;Sanchez</surname>
</string-name>, <string-name>
<given-names>A. K.</given-names>
<surname>Reddy</surname>
</string-name>, and <string-name>
<given-names>X. H. T.</given-names>
<surname>Wehrens</surname>
</string-name>, &#x0201c;<article-title>Characterization of Atrial and Ventricular Remodeling in an Improved Minimally Invasive Mouse Model of Transverse Aortic Constriction</article-title>,&#x0201d; <source>Journal of Cardiovascular Aging</source>
<volume>3</volume>, no. <issue>3</issue> (<year>2023</year>): <fpage>31</fpage>.<pub-id pub-id-type="pmid">37538440</pub-id>
</mixed-citation></ref><ref id="jcmm70617-bib-0032"><label>32</label><mixed-citation publication-type="journal" id="jcmm70617-cit-0032">
<string-name>
<given-names>H.</given-names>
<surname>Kondo</surname>
</string-name>, <string-name>
<given-names>I.</given-names>
<surname>Abe</surname>
</string-name>, <string-name>
<given-names>A.</given-names>
<surname>Fukui</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>Possible Role of Rivaroxaban in Attenuating Pressure&#x02010;Overload&#x02010;Induced Atrial Fibrosis and Fibrillation</article-title>,&#x0201d; <source>Journal of Cardiology</source>
<volume>71</volume>, no. <issue>3</issue> (<year>2018</year>): <fpage>310</fpage>&#x02013;<lpage>319</lpage>.<pub-id pub-id-type="pmid">28993090</pub-id>
</mixed-citation></ref><ref id="jcmm70617-bib-0033"><label>33</label><mixed-citation publication-type="journal" id="jcmm70617-cit-0033">
<string-name>
<given-names>K. M.</given-names>
<surname>Austin</surname>
</string-name>, <string-name>
<given-names>M. A.</given-names>
<surname>Trembley</surname>
</string-name>, <string-name>
<given-names>S. F.</given-names>
<surname>Chandler</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>Molecular Mechanisms of Arrhythmogenic Cardiomyopathy</article-title>,&#x0201d; <source>Nature Reviews. Cardiology</source>
<volume>16</volume>, no. <issue>9</issue> (<year>2019</year>): <fpage>519</fpage>&#x02013;<lpage>537</lpage>.<pub-id pub-id-type="pmid">31028357</pub-id>
</mixed-citation></ref><ref id="jcmm70617-bib-0034"><label>34</label><mixed-citation publication-type="journal" id="jcmm70617-cit-0034">
<string-name>
<given-names>R.</given-names>
<surname>Nusse</surname>
</string-name> and <string-name>
<given-names>H.</given-names>
<surname>Clevers</surname>
</string-name>, &#x0201c;<article-title>Wnt/&#x003b2;&#x02010;Catenin Signaling, Disease, and Emerging Therapeutic Modalities</article-title>,&#x0201d; <source>Cell</source>
<volume>169</volume>, no. <issue>6</issue> (<year>2017</year>): <fpage>985</fpage>&#x02013;<lpage>999</lpage>.<pub-id pub-id-type="pmid">28575679</pub-id>
</mixed-citation></ref><ref id="jcmm70617-bib-0035"><label>35</label><mixed-citation publication-type="journal" id="jcmm70617-cit-0035">
<string-name>
<given-names>D.</given-names>
<surname>Cai</surname>
</string-name>, <string-name>
<given-names>X.</given-names>
<surname>Wang</surname>
</string-name>, <string-name>
<given-names>Y.</given-names>
<surname>Sun</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>Patient&#x02010;Specific iPSC&#x02010;Derived Cardiomyocytes Reveal Aberrant Activation of Wnt/&#x003b2;&#x02010;Catenin Signaling in SCN5A&#x02010;Related Brugada Syndrome</article-title>,&#x0201d; <source>Stem Cell Research &#x00026; Therapy</source>
<volume>14</volume>, no. <issue>1</issue> (<year>2023</year>): <fpage>241</fpage>.<pub-id pub-id-type="pmid">37679791</pub-id>
</mixed-citation></ref><ref id="jcmm70617-bib-0036"><label>36</label><mixed-citation publication-type="journal" id="jcmm70617-cit-0036">
<string-name>
<given-names>X.</given-names>
<surname>Lv</surname>
</string-name>, <string-name>
<given-names>J.</given-names>
<surname>Li</surname>
</string-name>, <string-name>
<given-names>Y.</given-names>
<surname>Hu</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>Overexpression of miR&#x02010;27b&#x02010;3p Targeting Wnt3a Regulates the Signaling Pathway of Wnt/&#x003b2;&#x02010;Catenin and Attenuates Atrial Fibrosis in Rats With Atrial Fibrillation</article-title>,&#x0201d; <source>Oxidative Medicine and Cellular Longevity</source> (<year>2019</year>) <volume>2019</volume>: <elocation-id>5703764</elocation-id>, <pub-id pub-id-type="doi">10.1155/2019/5703764</pub-id>.<pub-id pub-id-type="pmid">31178968</pub-id>
</mixed-citation></ref><ref id="jcmm70617-bib-0037"><label>37</label><mixed-citation publication-type="journal" id="jcmm70617-cit-0037">
<string-name>
<given-names>A.</given-names>
<surname>Hiyama</surname>
</string-name>, <string-name>
<given-names>K.</given-names>
<surname>Yokoyama</surname>
</string-name>, <string-name>
<given-names>T.</given-names>
<surname>Nukaga</surname>
</string-name>, <string-name>
<given-names>D.</given-names>
<surname>Sakai</surname>
</string-name>, and <string-name>
<given-names>J.</given-names>
<surname>Mochida</surname>
</string-name>, &#x0201c;<article-title>A Complex Interaction Between Wnt Signaling and TNF&#x02010;&#x003b1; in Nucleus Pulposus Cells</article-title>,&#x0201d; <source>Arthritis Research &#x00026; Therapy</source>
<volume>15</volume>, no. <issue>6</issue> (<year>2013</year>): <fpage>R189</fpage>.<pub-id pub-id-type="pmid">24286133</pub-id>
</mixed-citation></ref><ref id="jcmm70617-bib-0038"><label>38</label><mixed-citation publication-type="journal" id="jcmm70617-cit-0038">
<string-name>
<given-names>R.</given-names>
<surname>Jiao</surname>
</string-name>, <string-name>
<given-names>H.</given-names>
<surname>Chen</surname>
</string-name>, <string-name>
<given-names>Q.</given-names>
<surname>Wan</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>Apigenin Inhibits Fibroblast Proliferation and Reduces Epidural Fibrosis by Regulating Wnt3a/&#x003b2;&#x02010;Catenin Signaling Pathway</article-title>,&#x0201d; <source>Journal of Orthopaedic Surgery and Research</source>
<volume>14</volume>, no. <issue>1</issue> (<year>2019</year>): <fpage>258</fpage>.<pub-id pub-id-type="pmid">31412883</pub-id>
</mixed-citation></ref><ref id="jcmm70617-bib-0039"><label>39</label><mixed-citation publication-type="journal" id="jcmm70617-cit-0039">
<string-name>
<given-names>C.</given-names>
<surname>Xue</surname>
</string-name> and <string-name>
<given-names>C. L.</given-names>
<surname>Mei</surname>
</string-name>, &#x0201c;<article-title>Polycystic Kidney Disease and Renal Fibrosis</article-title>,&#x0201d; <source>Advances in Experimental Medicine and Biology</source>
<volume>1165</volume> (<year>2019</year>): <fpage>81</fpage>&#x02013;<lpage>100</lpage>.<pub-id pub-id-type="pmid">31399962</pub-id>
</mixed-citation></ref><ref id="jcmm70617-bib-0040"><label>40</label><mixed-citation publication-type="journal" id="jcmm70617-cit-0040">
<string-name>
<given-names>F.</given-names>
<surname>Yang</surname>
</string-name>, <string-name>
<given-names>R.</given-names>
<surname>Hou</surname>
</string-name>, <string-name>
<given-names>X.</given-names>
<surname>Liu</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>Formula Attenuates Silica&#x02010;Induced Pulmonary Fibrosis by Suppressing Activation of Fibroblast via Regulating PI3K/AKT, JAK/STAT, and Wnt Signaling Pathway</article-title>,&#x0201d; <source>Phytomedicine: International Journal of Phytotherapy and Phytopharmacology</source>
<volume>110</volume> (<year>2023</year>): <fpage>154622</fpage>.<pub-id pub-id-type="pmid">36577208</pub-id>
</mixed-citation></ref><ref id="jcmm70617-bib-0041"><label>41</label><mixed-citation publication-type="journal" id="jcmm70617-cit-0041">
<string-name>
<given-names>B.</given-names>
<surname>Xu</surname>
</string-name>, <string-name>
<given-names>Y.</given-names>
<surname>Xu</surname>
</string-name>, <string-name>
<given-names>W.</given-names>
<surname>Ren</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>S&#x02010;Methyl&#x02010;L&#x02010;Cysteine Targeting MsrA Attenuates Ang II&#x02010;Induced Oxidative Stress and Atrial Remodeling via the p38 MAPK Signaling Pathway</article-title>,&#x0201d; <source>Food &#x00026; Function</source>
<volume>15</volume>, no. <issue>18</issue> (<year>2024</year>): <fpage>9165</fpage>&#x02013;<lpage>9175</lpage>.<pub-id pub-id-type="pmid">39157962</pub-id>
</mixed-citation></ref><ref id="jcmm70617-bib-0042"><label>42</label><mixed-citation publication-type="journal" id="jcmm70617-cit-0042">
<string-name>
<given-names>Q.</given-names>
<surname>Liu</surname>
</string-name>, <string-name>
<given-names>F.</given-names>
<surname>Zhang</surname>
</string-name>, <string-name>
<given-names>M.</given-names>
<surname>Yang</surname>
</string-name>, and <string-name>
<given-names>J.</given-names>
<surname>Zhong</surname>
</string-name>, &#x0201c;<article-title>Increasing Level of Interleukin&#x02010;1&#x003b2; in Epicardial Adipose Tissue Is Associated With Persistent Atrial Fibrillation</article-title>,&#x0201d; <source>Journal of Interferon &#x00026; Cytokine Research: The Official Journal of the International Society for Interferon and Cytokine Research</source>
<volume>40</volume>, no. <issue>1</issue> (<year>2020</year>): <fpage>64</fpage>&#x02013;<lpage>69</lpage>.<pub-id pub-id-type="pmid">31584315</pub-id>
</mixed-citation></ref><ref id="jcmm70617-bib-0043"><label>43</label><mixed-citation publication-type="journal" id="jcmm70617-cit-0043">
<string-name>
<given-names>Z.</given-names>
<surname>Liu</surname>
</string-name>, <string-name>
<given-names>Y.</given-names>
<surname>Zhang</surname>
</string-name>, <string-name>
<given-names>Z.</given-names>
<surname>Tang</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>Matrine Attenuates Cardiac Fibrosis by Affecting ATF6 Signaling Pathway in Diabetic Cardiomyopathy</article-title>,&#x0201d; <source>European Journal of Pharmacology</source>
<volume>804</volume> (<year>2017</year>): <fpage>21</fpage>&#x02013;<lpage>30</lpage>.<pub-id pub-id-type="pmid">28373137</pub-id>
</mixed-citation></ref><ref id="jcmm70617-bib-0044"><label>44</label><mixed-citation publication-type="journal" id="jcmm70617-cit-0044">
<string-name>
<given-names>Q.</given-names>
<surname>Lu</surname>
</string-name>, <string-name>
<given-names>X.</given-names>
<surname>Lin</surname>
</string-name>, <string-name>
<given-names>J.</given-names>
<surname>Wu</surname>
</string-name>, and <string-name>
<given-names>B.</given-names>
<surname>Wang</surname>
</string-name>, &#x0201c;<article-title>Matrine Attenuates Cardiomyocyte Ischemia&#x02010;Reperfusion Injury Through Activating AMPK/Sirt3 Signaling Pathway</article-title>,&#x0201d; <source>Journal of Receptor and Signal Transduction Research</source>
<volume>41</volume>, no. <issue>5</issue> (<year>2021</year>): <fpage>488</fpage>&#x02013;<lpage>493</lpage>.<pub-id pub-id-type="pmid">33019890</pub-id>
</mixed-citation></ref><ref id="jcmm70617-bib-0045"><label>45</label><mixed-citation publication-type="journal" id="jcmm70617-cit-0045">
<string-name>
<given-names>J.</given-names>
<surname>Yu</surname>
</string-name>, <string-name>
<given-names>S.</given-names>
<surname>Yang</surname>
</string-name>, <string-name>
<given-names>X.</given-names>
<surname>Wang</surname>
</string-name>, and <string-name>
<given-names>R.</given-names>
<surname>Gan</surname>
</string-name>, &#x0201c;<article-title>Matrine Improved the Function of Heart Failure in Rats via Inhibiting Apoptosis and Blocking &#x003b2;3&#x02010;Adrenoreceptor/Endothelial Nitric Oxide Synthase Pathway</article-title>,&#x0201d; <source>Molecular Medicine Reports</source>
<volume>10</volume>, no. <issue>6</issue> (<year>2014</year>): <fpage>3199</fpage>&#x02013;<lpage>3204</lpage>.<pub-id pub-id-type="pmid">25322941</pub-id>
</mixed-citation></ref><ref id="jcmm70617-bib-0046"><label>46</label><mixed-citation publication-type="journal" id="jcmm70617-cit-0046">
<string-name>
<given-names>J.</given-names>
<surname>Shi</surname>
</string-name>, <string-name>
<given-names>H.</given-names>
<surname>Zhang</surname>
</string-name>, <string-name>
<given-names>G.</given-names>
<surname>Han</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>Matrine Improves the Hepatic Microenvironment and Reverses Epithelial&#x02010;Mesenchymal Transition in Hepatocellular Carcinoma by Inhibiting the Wnt&#x02010;1/&#x003b2;&#x02010;Catenin Signaling Pathway</article-title>,&#x0201d; <source>American Journal of Translational Research</source>
<volume>15</volume>, no. <issue>8</issue> (<year>2023</year>): <fpage>5047</fpage>&#x02013;<lpage>5070</lpage>.<pub-id pub-id-type="pmid">37692966</pub-id>
</mixed-citation></ref><ref id="jcmm70617-bib-0047"><label>47</label><mixed-citation publication-type="journal" id="jcmm70617-cit-0047">
<string-name>
<given-names>Y.</given-names>
<surname>Lei</surname>
</string-name>, <string-name>
<given-names>X.</given-names>
<surname>Li</surname>
</string-name>, and <string-name>
<given-names>L.</given-names>
<surname>Zhu</surname>
</string-name>, &#x0201c;<article-title>Matrine Regulates miR&#x02010;495&#x02010;3p/miR&#x02010;543/PDK1 Axis to Repress the Progression of Acute Myeloid Leukemia via the Wnt/&#x003b2;&#x02010;Catenin Pathway</article-title>,&#x0201d; <source>Chemical Biology &#x00026; Drug Design</source>
<volume>103</volume>, no. <issue>1</issue> (<year>2024</year>): <elocation-id>e14441</elocation-id>.<pub-id pub-id-type="pmid">38230785</pub-id>
</mixed-citation></ref><ref id="jcmm70617-bib-0048"><label>48</label><mixed-citation publication-type="journal" id="jcmm70617-cit-0048">
<string-name>
<given-names>T.</given-names>
<surname>Li</surname>
</string-name>, <string-name>
<given-names>X.</given-names>
<surname>Weng</surname>
</string-name>, <string-name>
<given-names>S.</given-names>
<surname>Cheng</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>Wnt3a Upregulation Is Involved in TGF&#x003b2;1&#x02010;Induced Cardiac Hypertrophy</article-title>,&#x0201d; <source>Cytokine</source>
<volume>138</volume> (<year>2021</year>): <elocation-id>155376</elocation-id>.<pub-id pub-id-type="pmid">33243628</pub-id>
</mixed-citation></ref><ref id="jcmm70617-bib-0049"><label>49</label><mixed-citation publication-type="miscellaneous" id="jcmm70617-cit-0049">
<string-name>
<given-names>H. D.</given-names>
<surname>Hui Ma</surname>
</string-name>, <string-name>
<given-names>S.</given-names>
<surname>Wei</surname>
</string-name>, <string-name>
<given-names>X.</given-names>
<surname>Yang</surname>
</string-name>, and <string-name>
<given-names>W.</given-names>
<surname>Zhang</surname>
</string-name>, <article-title>&#x0201c;Protective Effects of Matrine on Acute Myocardial Hypertrophy Induced by Isoproterenol via Akt/mTOR/p70S6K/eIF4E Signaling Pathway in Rats,&#x0201d;</article-title>
<italic toggle="yes">bioRxiv</italic>, The Preprint Server for Biology (<year>2021</year>), <pub-id pub-id-type="doi">10.1101/2021.01.15.426879</pub-id>.</mixed-citation></ref><ref id="jcmm70617-bib-0050"><label>50</label><mixed-citation publication-type="journal" id="jcmm70617-cit-0050">
<string-name>
<given-names>R.</given-names>
<surname>Feng</surname>
</string-name>, <string-name>
<given-names>J.</given-names>
<surname>Wan</surname>
</string-name>, <string-name>
<given-names>Y.</given-names>
<surname>He</surname>
</string-name>, <string-name>
<given-names>H.</given-names>
<surname>Gong</surname>
</string-name>, <string-name>
<given-names>Z.</given-names>
<surname>Xu</surname>
</string-name>, and <string-name>
<given-names>J.</given-names>
<surname>Feng</surname>
</string-name>, &#x0201c;<article-title>Angiotensin&#x02010;Receptor Blocker Losartan Alleviates Atrial Fibrillation in Rats by Downregulating Frizzled 8 and Inhibiting the Activation of WNT&#x02010;5A Pathway</article-title>,&#x0201d; <source>Clinical and Experimental Pharmacology &#x00026; Physiology</source>
<volume>50</volume>, no. <issue>1</issue> (<year>2023</year>): <fpage>19</fpage>&#x02013;<lpage>27</lpage>.<pub-id pub-id-type="pmid">36047789</pub-id>
</mixed-citation></ref></ref-list></back></article>